{"gene":"GREM1","run_date":"2026-06-10T01:55:21","timeline":{"discoveries":[{"year":1999,"finding":"Gremlin is a member of the DAN family of BMP antagonists that binds and blocks BMP2, BMP4, and BMP7; exogenous recombinant Gremlin in the developing avian limb controls outgrowth, restricts programmed cell death, confines chondrogenesis, and regulates interdigital tissue regression, all mediated by neutralization of BMP signaling.","method":"In vivo administration of recombinant protein in chick embryo limb bud; expression analysis by in situ hybridization","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct in vivo functional rescue/gain-of-function with defined cellular phenotypes (outgrowth, apoptosis, chondrogenesis), replicated across multiple developmental stages and independently consistent with biochemical data on BMP binding","pmids":["10556075"],"is_preprint":false},{"year":2000,"finding":"Drm/Gremlin is synthesized as a secreted glycoprotein that exists in both glycosylated and non-glycosylated forms; both undergo phosphorylation. The protein is present on the external cell surface and within the ER/Golgi. Both cell-associated and secreted forms bind 125I-BMP-4 and antagonize BMP signaling.","method":"Metabolic labeling, SDS-PAGE, confocal immunofluorescence microscopy, 125I-BMP-4 binding assay, BMP signaling reporter assay","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — multiple orthogonal biochemical methods (radiolabeled ligand binding, metabolic labeling, confocal localization, functional signaling assay) in a single focused study","pmids":["10722723"],"is_preprint":false},{"year":2003,"finding":"Gremlin (Cktsf1b1) is the principal BMP antagonist required for early limb outgrowth and patterning in mice; its loss interrupts the positive feedback loop between the zone of polarizing activity (ZPA/Shh) and the apical ectodermal ridge (AER/Fgf), resulting in abnormal skeletal patterning. The gremlin mutation is allelic to the limb deformity (ld) mutation.","method":"Mouse knockout/genetic mutation, in vivo skeletal phenotyping, genetic epistasis (allele complementation)","journal":"Nature Genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — loss-of-function mouse genetics with clear pathway epistasis, allelic complementation with independent ld mutation","pmids":["12808456"],"is_preprint":false},{"year":2002,"finding":"Drm/Gremlin overexpression in tumor-derived cell lines (Daoy, Saos-2) inhibits tumorigenesis, increases p21(Cip1) protein levels via a p53- and MAP kinase-independent transcriptional mechanism, and reduces phospho-p42/44 MAP kinase levels.","method":"Ecdysone-inducible and constitutive overexpression in tumor cell lines; Western blot for p21(Cip1) and phospho-p42/44 MAPK; tumorigenicity assays","journal":"Biochemical and Biophysical Research Communications","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — gain-of-function in multiple cell lines with two orthogonal readouts (p21 induction, MAPK phosphorylation), single lab","pmids":["12135612"],"is_preprint":false},{"year":2004,"finding":"Drm/Gremlin and Dan physically interact with Slit1 and Slit2 proteins; this binding depends on glycosylation of Drm and is not competed by BMPs. Drm and Dan function as inhibitors of monocyte chemotaxis induced by SDF-1α or fMLP; Dan's inhibition is not due to blocking SDF-1α binding to its receptor.","method":"Co-immunoprecipitation/pulldown, monocyte chemotaxis assays, competitive binding assays","journal":"Journal of Immunology","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — direct binding demonstrated by pulldown plus functional chemotaxis assay, with mechanistic dissection ruling out one mechanism; single lab","pmids":["15528323"],"is_preprint":false},{"year":2006,"finding":"Drm/Gremlin is a proangiogenic factor expressed by endothelium that stimulates endothelial cell migration and invasion in fibrin and collagen gels, binds with high affinity to endothelial cells, triggers tyrosine phosphorylation of intracellular signaling proteins, and induces neovascularization in the chick chorioallantoic membrane. This proangiogenic activity is BMP4-independent: BMP4 does not affect Drm/Gremlin–endothelium interaction.","method":"Protein purification from conditioned medium using endothelial sprouting assay; recombinant protein binding studies; in vitro migration/invasion assays; CAM neovascularization assay; tyrosine phosphorylation Western blot","journal":"Blood","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — protein purified to homogeneity from conditioned medium, multiple orthogonal functional assays (migration, invasion, in vivo CAM), BMP-independence demonstrated","pmids":["17077323"],"is_preprint":false},{"year":2006,"finding":"BMP activity is necessary and sufficient for induction of Gremlin expression in the posterior limb bud (low BMP2 upregulates Gremlin; high BMP2 downregulates it). Shh activity is required to exclude Gremlin from the posterior limb domain, thereby terminating the Shh-Fgf4 signaling loop.","method":"Bead implantation assays (BMP2, Noggin beads in chick limb), oligozeugodactyly mutant limbs lacking Shh, cyclopamine Shh blockade, in vivo limb mesenchyme cultures","journal":"Developmental Biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple gain- and loss-of-function experiments in vivo and ex vivo, epistasis with Shh established via genetic and pharmacological approaches","pmids":["16989805"],"is_preprint":false},{"year":2007,"finding":"Gremlin promotes vascular smooth muscle cell (VSMC) proliferation and migration by blocking BMP signaling; stable overexpression blocks BMP-induced reduction of DNA synthesis, accelerates cell cycle progression through p27(kip1) down-regulation, and increases migration. Gremlin expression in VSMCs is induced by angiotensin II, TGF-β1, and PDGF, and is elevated in neointima of balloon-injured carotid arteries.","method":"Stable overexpression, gene silencing (siRNA), DNA synthesis assay, cell counting, cell cycle analysis, migration assay, in vivo balloon injury model, Western blot","journal":"Journal of Molecular and Cellular Cardiology","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — reciprocal gain- and loss-of-function with defined cellular readouts; single lab","pmids":["18086474"],"is_preprint":false},{"year":2009,"finding":"Allelic depletion of grem1 in streptozotocin-diabetic mice (grem1+/-) attenuates diabetic kidney disease: pSmad1/5/8 (BMP signaling) is maintained in grem1+/- kidneys (unlike wild-type diabetic kidneys), and markers of renal damage (fibronectin, CTGF, glomerular basement membrane thickening, microalbuminuria) are reduced, placing grem1 as a BMP antagonist driving renal injury.","method":"Grem1 heterozygous knockout mouse, streptozotocin diabetes model, immunohistochemistry, Western blot for pSmad1/5/8 and fibrosis markers, microalbuminuria measurement","journal":"Diabetes","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic loss-of-function in disease model with multiple orthogonal readouts including pathway-level mechanistic marker (pSmad); single lab","pmids":["19401426"],"is_preprint":false},{"year":2011,"finding":"Six1 regulates Grem1 expression in the metanephric mesenchyme (MM) to initiate ureteric bud branching morphogenesis: Six1-/- mice lack Grem1 expression in the MM, causing failure of ampulla formation. Restoring GREM1 protein to Six1-/- kidney rudiments rescues branching. Genetic reduction of BMP4 in Six1-/- mice (Six1-/-; Bmp4+/-) also restores urinary tract morphogenesis, placing Grem1 downstream of Six1 and upstream of BMP4 in this pathway.","method":"Six1 knockout mice, GREM1 protein rescue experiment, genetic epistasis (Six1-/-; Bmp4+/- double mutant), in vitro kidney rudiment culture","journal":"Developmental Biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis plus protein rescue experiment, orthogonal approaches establish pathway order (Six1→Grem1→BMP4)","pmids":["21281623"],"is_preprint":false},{"year":2012,"finding":"Gremlin-1 binds various cancer cell lines independently of BMP-2, BMP-4, BMP-7, and VEGFR2. This BMP-independent binding promotes cell migration, invasion, proliferation, and EMT (decreased E-cadherin), all of which are blocked by a neutralizing anti-gremlin-1 antibody (GRE1).","method":"Cell binding assays, antibody blocking, scratch wound healing assay, invasion assay, stable gremlin-1 transfection, E-cadherin immunostaining","journal":"PLoS ONE","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — multiple functional readouts with antibody neutralization confirming specificity; BMP- and VEGFR2-independence tested directly; single lab","pmids":["22514712"],"is_preprint":false},{"year":2015,"finding":"Gremlin (VEGFR2 agonist) binds to VEGFR2 in renal proximal tubular epithelial cells and activates VEGFR2 signaling independently of its BMP antagonism. In vivo administration of recombinant gremlin to murine kidneys activates VEGFR2 signaling and triggers NF-κB-driven renal inflammation and immune cell infiltration; VEGFR2 blockade diminishes these effects.","method":"Recombinant gremlin administration in vivo and in vitro, VEGFR2 binding assay, VEGFR2 kinase inhibitor treatment, co-immunoprecipitation/binding in tubular cells, NF-κB activation by Western blot, histological analysis of inflammatory infiltrate","journal":"Journal of Pathology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — direct binding demonstrated, in vivo and in vitro functional validation, receptor pathway blockade confirming mechanism; single lab with multiple orthogonal methods","pmids":["25810250"],"is_preprint":false},{"year":2015,"finding":"Gremlin 1 defines a skeletal stem cell population (osteochondroreticular, OCR) in bone marrow metaphysis that self-renews and gives rise to osteoblasts, chondrocytes, and reticular marrow stromal cells (but not adipocytes); Grem1 expression is required for bone development, bone remodeling, and fracture repair. Grem1 also identifies intestinal reticular stem cells (iRSCs) that are cells of origin for the periepithelial intestinal mesenchymal sheath.","method":"Gremlin-1-Cre fate-mapping in mice, clonal analysis, in vivo bone development and fracture repair models, flow cytometry, transplantation assays","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — Cre-based in vivo fate mapping plus functional depletion and transplantation, multiple independent phenotypic readouts","pmids":["25594183"],"is_preprint":false},{"year":2015,"finding":"Gremlin 1 (along with FRZB and DKK1) inhibits hypertrophic differentiation of human articular chondrocytes, maintaining cartilage homeostasis. Supplementation of these proteins diminishes terminal hypertrophic differentiation without affecting chondrogenesis in long-bone explant cultures and in chondrogenically differentiating human MSCs.","method":"Recombinant protein supplementation in long-bone explant cultures and human MSC chondrogenic differentiation; gene expression profiling; whole-genome microarray","journal":"Arthritis and Rheumatism","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — functional rescue with recombinant protein in two model systems; single lab","pmids":["22576962"],"is_preprint":false},{"year":2015,"finding":"Gremlin induces ocular hypertension in mice via Smad3-dependent signaling in the trabecular meshwork (TM): intravitreal Ad5.Gremlin elevates IOP and upregulates fibronectin and collagen-1 expression in TM of Smad3 wild-type but not Smad3 HET or KO mice. Gremlin and TGFβ2 reciprocally increase each other's expression in the TM.","method":"Intravitreal adenoviral injection in wild-type vs. Smad3 knockout mice, IOP measurement, Western blot, immunofluorescence, qPCR","journal":"Investigative Ophthalmology & Visual Science","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic epistasis (Smad3 KO) combined with in vivo gain-of-function, multiple readouts; single lab","pmids":["26284554"],"is_preprint":false},{"year":2015,"finding":"Gremlin 1 is a key pro-fibrogenic factor in chronic pancreatitis: TGF-β induces Grem1 expression in pancreatic stellate cells; Grem1 blocks BMP2-induced Smad1/5 phosphorylation and abolishes BMP2's suppression of TGF-β-induced collagen expression. Grem1+/- mice show ~33% reduction in pancreatic fibrosis.","method":"Mouse CP model (cerulein), Grem1+/- knockout mice, isolated pancreatic stellate cell cultures, recombinant Grem1 protein treatment, Smad1/5 phosphorylation Western blot, collagen quantification","journal":"Journal of Molecular Medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic loss-of-function in vivo plus in vitro biochemical mechanism (Smad1/5 phosphorylation), TGF-β induction of Grem1 shown; multiple orthogonal methods","pmids":["26141517"],"is_preprint":false},{"year":2016,"finding":"Crystal structure of Gremlin-1 reveals a conserved dimeric structure similar to other DAN family inhibitors. Biophysical analysis shows Gremlin-1 and BMP-2 form larger oligomeric complexes beyond 1:1 stoichiometry. Mutagenesis mapped the Gremlin-1 binding site on BMP-2, revealing a mechanism of BMP inhibition distinct from Noggin and Chordin.","method":"X-ray crystallography (crystal structure of Gremlin-1), biolayer interferometry (BLI) binding kinetics, site-directed mutagenesis of BMP-2","journal":"Biochemical Journal","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structure plus biophysical binding quantification plus mutagenesis; single lab but multiple rigorous orthogonal methods","pmids":["27036124"],"is_preprint":false},{"year":2016,"finding":"GREM1 is a direct transcriptional target of CDX2 and TCF7L2 (Wnt effector): the CRC risk allele at rs16969681 lies in active chromatin with enhancer activity; CDX2 and TCF7L2 bind this region with higher affinity for the risk allele, driving stronger GREM1 expression. Higher Grem1 mRNA increases intestinal tumor burden in ApcMin mice.","method":"Chromatin accessibility/enhancer reporter assay, allele-specific CDX2/TCF7L2 binding assay, CDX2 overexpression-driven GREM1 re-expression, ApcMin mouse model with Grem1 dosage manipulation","journal":"Cell Reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (chromatin assay, TF binding, in vivo mouse model); single lab","pmids":["25131200"],"is_preprint":false},{"year":2018,"finding":"Gremlin activates the Notch signaling pathway in kidney tubular cells: recombinant gremlin upregulates Jagged-1, induces nuclear translocation of active Notch-1 (N1ICD), and upregulates Notch effectors hes-1 and hey-1 in vitro and in vivo. This Notch activation is linked to NF-κB-mediated renal inflammation.","method":"In vitro tubular cell culture, in vivo murine renal gremlin injection, γ-secretase inhibitor (DAPT) Notch blockade, Western blot for N1ICD, gene expression analysis","journal":"Clinical Science","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — both in vitro and in vivo evidence for pathway activation, pathway inhibitor confirms mechanism; single lab","pmids":["29720422"],"is_preprint":false},{"year":2018,"finding":"SLIT2 and Gremlin interact directly: the SLIT2-Gremlin interaction inhibits both SLIT2-ROBO2 signaling in neurons and Gremlin antagonism of BMP activity in myoblasts and fibroblasts. BMP2 down-regulates SLIT2 expression through canonical BMP/SMAD4 signaling; Gremlin treatment, BMP receptor inhibition, or SMAD4 knockdown rescues SLIT2 repression—revealing negative cross-talk between the SLIT2 and BMP-Gremlin pathways.","method":"Direct binding assays, SLIT2-ROBO2 signaling assay in neurons, BMP activity assay in myoblasts/fibroblasts, SLIT2 promoter activity assay, SMAD4 knockdown, BMP receptor inhibition","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — direct binding, functional epistasis in multiple cell types, promoter assay, and genetic knockdown; multiple orthogonal methods in single study","pmids":["29317497"],"is_preprint":false},{"year":2019,"finding":"Cancer-associated fibroblast (CAF)-derived Grem1 abrogates BMP/SMAD signaling in breast cancer cells, promoting mesenchymal phenotype, stemness, and invasion. TGF-β secreted by breast cancer cells stimulates GREM1 expression in CAFs. Grem1 also promotes fibrogenic activation of CAFs and breast cancer cell intravasation and extravasation in zebrafish xenograft models.","method":"In situ hybridization, recombinant protein treatment, SMAD signaling assay, functional cell-based assays (stemness, invasion), collagen contraction assay, zebrafish xenograft co-injection model","journal":"Breast Cancer Research","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — multiple functional assays plus in vivo zebrafish model; single lab","pmids":["31533776"],"is_preprint":false},{"year":2020,"finding":"GREM1 promotes breast cancer cell metastasis by activating STAT3, which drives MMP13 transcription. GREM1 knockdown reduces tumor growth and lung metastasis in an orthotopic mouse model.","method":"GREM1 knockdown/overexpression, orthotopic mouse model, STAT3 activation assay, MMP13 expression analysis, migration/invasion assays","journal":"International Journal of Molecular Sciences","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — in vitro pathway activation combined with in vivo model; single lab","pmids":["33287358"],"is_preprint":false},{"year":2020,"finding":"Gremlin-1 activates VEGFR2-Akt-mTORC2 signaling in retinal pigment epithelial (RPE) cells to promote cell proliferation, migration, and VEGF production; VEGFR2 inhibition or knockdown, and mTORC2 component knockdown (Rictor, Sin1), abolished these effects.","method":"Pharmacological inhibition (SU5416), shRNA knockdown of VEGFR2/mTORC2 components, Western blot for p-Akt/mTORC2, proliferation/migration assays, VEGF ELISA","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — multiple pathway inhibitors and knockdowns confirm VEGFR2-Akt-mTORC2 axis; single lab","pmids":["27894090"],"is_preprint":false},{"year":2020,"finding":"GREM1 in rheumatoid arthritis fibroblast-like synoviocytes (RA-FLS) promotes cell proliferation, survival, migration, and invasion via αvβ3 integrin signaling: GREM1 siRNA reduces pErk1/2, pAkt, and Bcl2 while increasing Bax expression; these effects are completely blocked by anti-αvβ3 integrin neutralizing antibodies.","method":"siRNA knockdown, recombinant GREM1 treatment, αvβ3 integrin neutralizing antibody, Western blot for signaling proteins, cell proliferation/migration/invasion assays","journal":"Journal of Rheumatology","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — integrin neutralization identifies receptor mediating BMP-independent signaling; multiple functional and biochemical readouts; single lab","pmids":["26834210"],"is_preprint":false},{"year":2020,"finding":"GREM1 activates Akt/STAT3 signaling to increase glycolysis in breast cancer cells by upregulating hexokinase-2 (HK2) expression; this operates via a ROS-Akt-STAT3 axis and increases glucose uptake and lactate production.","method":"GREM1 overexpression, glucose uptake/lactate production assays, Western blot for STAT3/Akt/HK2, ROS measurement, signaling inhibitors","journal":"Biochemical and Biophysical Research Communications","confidence":"Low","confidence_rationale":"Tier 3 / Weak — functional assays with signaling Western blots; single lab, single study, no orthogonal validation of the specific ROS-Akt-STAT3-HK2 chain","pmids":["33097188"],"is_preprint":false},{"year":2021,"finding":"Stromal Grem1 upregulation from topographically distinct fibroblast populations is required for adaptive BMP pathway attenuation during intestinal regeneration after ulceration; this Grem1-mediated BMP antagonism is obligatory but functionally submaximal for regenerative stem cell reprogramming. Mechanistically, BMP pathway activation (via Bmp4) abrogates regenerative stem cell dedifferentiation despite convergent YAP/TAZ effects on cell fate.","method":"Novel mouse model (autocrine Bmp4 ligand), spatial BMP signaling mapping (mouse and human), Grem1 deletion transgenic mice, Bmp4 or Grem1 epithelial overexpression, intestinal regeneration assays","journal":"Gastroenterology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple transgenic models, spatial mapping in human and mouse tissue, functional epithelial overexpression and genetic deletion; independent replication in human tissue","pmids":["33819486"],"is_preprint":false},{"year":2021,"finding":"Grem1+ fibroblastic reticular cells (FRCs) localize at T-B cell junctions in secondary lymphoid organs and are required for homeostatic maintenance of resident conventional dendritic cells (cDCs): Grem1+ FRC depletion causes preferential loss, decreased homeostatic proliferation and survival of cDCs, and compromised T cell immunity.","method":"scRNA-seq (human and mouse lymph nodes), Grem1-CreERT2 knock-in mice for genetic depletion, multi-omics characterization, flow cytometry, functional T cell immunity assays","journal":"Nature Immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic Cre-based depletion with multiple orthogonal functional readouts; human and mouse scRNA-seq validation; independent transcriptomic and cellular phenotypic methods","pmids":["33903764"],"is_preprint":false},{"year":2022,"finding":"Grem1 inhibits the expression of EMT transcription factors Snai1 (Snail) and Snai2 (Slug) in epithelial PDAC cells, maintaining epithelial identity by suppressing BMP activity. Grem1 inactivation in established PDAC causes direct conversion of epithelial to mesenchymal cells; conversely, Grem1 overexpression causes epithelialization of mesenchymal PDAC cells. This paracrine mechanism (Grem1 expressed in mesenchymal cells, acting on epithelial cells) is required to maintain cellular heterogeneity in pancreatic cancer.","method":"Conditional Grem1 knockout in established PDAC mouse tumors, Grem1 overexpression in mesenchymal PDAC cells, time-course cell fate analysis, Snai1/Snai2 expression analysis, human PDAC validation","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — bidirectional genetic manipulation (KO and OE) in established tumors with rapid phenotypic readout, molecular mechanism identified (Snail/Slug suppression), human validation","pmids":["35768509"],"is_preprint":false},{"year":2022,"finding":"Grem1 accelerates nucleus pulposus cell apoptosis in intervertebral disc degeneration by inhibiting TGF-β-mediated Smad2/3 phosphorylation: Grem1 siRNA reduces apoptosis in TNF-α-induced degenerative NP cells and inhibits IVDD progression in vivo.","method":"siRNA knockdown, flow cytometry for apoptosis, Western blot for p-Smad2/3, immunofluorescence, in vivo IVDD rat model with local siRNA injection","journal":"Experimental & Molecular Medicine","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — in vitro and in vivo genetic knockdown with defined pathway readout (Smad2/3 phosphorylation); single lab","pmids":["35440754"],"is_preprint":false},{"year":2020,"finding":"Grem1 depletion in adult mice causes fatal enteropathy (failure of epithelial cell replication and maturation, villous atrophy) and bone marrow failure with haematopoietic insufficiency, demonstrating an essential homeostatic role for Grem1 in maintaining intestinal epithelial renewal and haematopoiesis.","method":"Inducible Grem1 conditional knockout (ROSA26CreER-Grem1flx/flx) in adult mice, tamoxifen induction, histopathology, assessment of epithelial proliferation and bone marrow cellularity","journal":"Journal of Pathology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — inducible genetic deletion in adult animals with severe, reproducible phenotypic readouts; defined time course","pmids":["32297672"],"is_preprint":false},{"year":2022,"finding":"GREM1 and ISLR are CAF-specific genes that antagonistically regulate stromal BMP signaling in colorectal cancer: GREM1 inhibits BMP signaling while ISLR promotes it. They mark distinct fibroblast subpopulations differentially regulated by TGF-β and FOXL1. GREM1-neutralizing antibody or fibroblast Islr overexpression reduces CRC tumoroid growth and promotes Lgr5+ stem cell differentiation. AAV8-mediated Islr delivery to hepatocytes increased BMP signaling and improved survival in a mouse liver metastasis model.","method":"Human CRC RNA analysis, in situ hybridization, CRC tumoroid assays with GREM1-neutralizing antibody, fibroblast Islr overexpression, AAV8 gene delivery in mouse hepatic metastasis model, BMP signaling assays","journal":"Gastroenterology","confidence":"High","confidence_rationale":"Tier 2 / Strong — neutralizing antibody, genetic overexpression, and AAV gene delivery in vivo; multiple orthogonal functional assays with pathway-level readout","pmids":["33197448"],"is_preprint":false},{"year":2022,"finding":"Gremlin-1 induces endothelial-to-mesenchymal transition (EndMT) in pulmonary artery endothelial cells (PAECs) via phospho-Smad2/3-dependent signaling; BMP-7 reverses Gremlin-1-induced EndMT by inducing phospho-Smad1/5/8 and suppressing phospho-Smad2/3.","method":"Recombinant gremlin-1 treatment, BMP-7 treatment, immunofluorescence for EndMT markers (α-SMA, VWF), Western blot for Smad phosphorylation, migration and tube formation assays","journal":"Experimental Cell Research","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — direct mechanistic dissection of Smad2/3 vs. Smad1/5/8 pathway balance with multiple functional readouts; single lab","pmids":["32145252"],"is_preprint":false},{"year":2022,"finding":"In NAFLD/NASH, Gremlin 1 (expressed highly in visceral fat) is pro-senescent and antagonistic to BMP4. BMP4 is anti-senescent, anti-steatotic, anti-inflammatory and anti-fibrotic in liver cell spheroids. Both senescence and anti-senescence factors target the YAP/TAZ pathway in this context.","method":"Human liver biopsies (n=58), liver cell spheroids (stellate and hepatocyte cells), recombinant BMP4 and Gremlin 1 treatment, senescence markers, YAP/TAZ pathway assays, machine learning analysis","journal":"Nature Metabolism","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — functional spheroid experiments with direct protein treatment; pathway (YAP/TAZ) implicated; single lab","pmids":["35995996"],"is_preprint":false},{"year":2014,"finding":"Aberrant epithelial GREM1 expression (caused by the HMPS duplication) disrupts homeostatic intestinal BMP morphogen gradients, alters cell fate along the vertical epithelial axis, and promotes persistence/reacquisition of stem cell properties in Lgr5-negative progenitor cells that have exited the stem cell niche, enabling ectopic crypt formation and cancer initiation from non-stem cells.","method":"HMPS patient tissue analysis, mouse model of GREM1 epithelial overexpression, BMP gradient mapping, Lgr5 lineage tracing, histology, somatic mutation analysis","journal":"Nature Medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — human tissue combined with mouse disease model, mechanistic BMP gradient disruption demonstrated, cell-fate consequence quantified","pmids":["25419707"],"is_preprint":false},{"year":2023,"finding":"Grem1 marks a bipotent chondrogenic/osteogenic progenitor cell population within the articular surface; these progenitors are depleted by injury-induced OA and aging, and their genetic ablation causes OA in mice. Foxo1 is required for Grem1-lineage cell survival (Foxo1 ablation in Grem1-lineage cells causes OA). FGFR3 pathway activation by FGF18 drives Grem1-lineage chondrocyte progenitor proliferation, increases cartilage thickness, and reduces OA.","method":"Grem1-Cre lineage tracing, genetic cell ablation in mice, Foxo1 conditional knockout in Grem1-lineage cells, FGF18 administration, transcriptomic analysis, OA scoring","journal":"Nature Communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple genetic models (ablation, conditional KO, fate-mapping), FGF18 therapeutic intervention, multiple orthogonal functional readouts","pmids":["37907525"],"is_preprint":false}],"current_model":"GREM1 (Gremlin-1) is a secreted, dimeric cysteine-knot glycoprotein that primarily acts as an extracellular antagonist of BMP2, BMP4, and BMP7 by forming stoichiometrically complex oligomers with BMP dimers, thereby preventing BMP receptor activation; it also signals independently of BMPs by binding VEGFR2 to drive angiogenesis, NF-κB-mediated inflammation, and endothelial/epithelial-mesenchymal transitions, and by engaging αvβ3 integrin to promote cell survival and migration; in development, GREM1 acts downstream of Six1 and is regulated by BMP/Shh cross-talk to maintain the ZPA-AER feedback loop required for limb patterning; in adult tissues it maintains intestinal epithelial homeostasis (by attenuating the BMP differentiation gradient near the crypt stem cell niche), marks skeletal and articular chondrocyte stem cell populations, and is induced by TGF-β to drive fibrosis in kidney, pancreas, and lung by blocking protective BMP signaling."},"narrative":{"mechanistic_narrative":"GREM1 (Gremlin-1) is a secreted, dimeric cysteine-knot glycoprotein of the DAN family that functions principally as an extracellular antagonist of BMP2, BMP4, and BMP7, controlling BMP-dependent cell fate decisions across development, tissue homeostasis, and disease [PMID:10556075, PMID:27036124]. It is synthesized as both glycosylated and non-glycosylated phosphorylated forms that localize to the ER/Golgi and the external cell surface, where both cell-associated and secreted protein bind BMP-4 and block its signaling [PMID:10722723]. Structural and biophysical analysis shows GREM1 forms larger-than-1:1 oligomeric complexes with BMP-2 through a binding interface mapped on the ligand, defining a mode of inhibition distinct from Noggin and Chordin [PMID:27036124]. In limb development GREM1 is the principal BMP antagonist sustaining the Shh(ZPA)-Fgf(AER) feedback loop, with its own expression tuned by BMP dose and spatially restricted by Shh [PMID:12808456, PMID:16989805]; in kidney morphogenesis it acts downstream of Six1 and upstream of BMP4 to permit ureteric bud branching [PMID:21281623]. In adult tissues GREM1 maintains homeostasis by attenuating BMP signaling near stem/progenitor niches: it marks and is required by skeletal osteochondroreticular stem cells, intestinal reticular stem cells, and articular cartilage progenitors, and its loss causes fatal enteropathy and bone marrow failure [PMID:25594183, PMID:32297672, PMID:37907525]. Aberrant or stromally derived GREM1 disrupts the intestinal BMP gradient to reprogram non-stem progenitors and drive tumorigenesis, with expression driven by CDX2/TCF7L2 enhancer binding and by TGF-β in cancer-associated fibroblasts [PMID:25419707, PMID:25131200, PMID:31533776, PMID:33197448]. Beyond BMP antagonism, GREM1 signals independently of BMPs: it binds VEGFR2 to activate Akt/mTORC2 and NF-κB-driven inflammation and angiogenesis [PMID:17077323, PMID:25810250, PMID:27894090], engages αvβ3 integrin to promote survival and migration [PMID:26834210], and modulates Smad2/3 (TGF-β) and Notch signaling to drive epithelial- and endothelial-to-mesenchymal transitions and fibrosis in kidney, pancreas, lung, and eye [PMID:19401426, PMID:26141517, PMID:29720422, PMID:32145252, PMID:26284554]. GREM1 also binds SLIT1/SLIT2 in a glycosylation-dependent manner, mediating reciprocal negative cross-talk between the SLIT-ROBO and BMP-Gremlin pathways and inhibiting monocyte chemotaxis [PMID:15528323, PMID:29317497].","teleology":[{"year":1999,"claim":"Established GREM1's foundational identity as a DAN-family BMP antagonist whose neutralization of BMP signaling controls limb outgrowth, apoptosis, and chondrogenesis, answering what this secreted protein does at the tissue level.","evidence":"Recombinant protein administration and in situ hybridization in chick limb bud","pmids":["10556075"],"confidence":"High","gaps":["Did not resolve molecular stoichiometry of BMP binding","Mammalian genetic requirement not yet shown"]},{"year":2000,"claim":"Defined GREM1 as a secreted, glycosylated, phosphorylated glycoprotein present both at the cell surface and in the secretory pathway, with both forms competent to bind and block BMP-4, clarifying its biosynthesis and where it acts.","evidence":"Metabolic labeling, confocal immunofluorescence, 125I-BMP-4 binding and reporter assays","pmids":["10722723"],"confidence":"High","gaps":["Functional role of phosphorylation unresolved","Structural basis of BMP binding not addressed"]},{"year":2003,"claim":"Demonstrated by mouse loss-of-function that GREM1 is genetically required to sustain the ZPA-AER feedback loop for limb patterning, moving from gain-of-function to in vivo necessity.","evidence":"Mouse knockout, skeletal phenotyping, allelic complementation with limb deformity mutation","pmids":["12808456"],"confidence":"High","gaps":["Upstream regulation of Grem1 expression not defined here"]},{"year":2006,"claim":"Resolved the regulatory logic of Grem1 in the limb, showing BMP dose tunes its expression and Shh restricts its domain to terminate the signaling loop.","evidence":"Bead implantation, Shh-deficient mutants, cyclopamine blockade, limb mesenchyme culture","pmids":["16989805"],"confidence":"High","gaps":["Direct transcriptional mediators not identified","Generalizability to other tissues untested"]},{"year":2006,"claim":"Revealed a BMP-independent proangiogenic function, the first evidence that GREM1 signals through receptors other than BMP ligands.","evidence":"Protein purification by endothelial sprouting, migration/invasion assays, CAM neovascularization, tyrosine phosphorylation","pmids":["17077323"],"confidence":"High","gaps":["Endothelial receptor identity not yet defined","Intracellular signaling cascade only partly mapped"]},{"year":2004,"claim":"Identified SLIT1/SLIT2 as glycosylation-dependent GREM1/DAN binding partners and linked GREM1 to inhibition of monocyte chemotaxis, broadening its interactome beyond BMPs.","evidence":"Co-immunoprecipitation/pulldown, monocyte chemotaxis and competitive binding assays","pmids":["15528323"],"confidence":"Medium","gaps":["Receptor mediating chemotaxis inhibition unknown","Single lab, in vitro binding"]},{"year":2002,"claim":"Provided early evidence that GREM1 overexpression can suppress tumorigenesis and induce p21 via a p53/MAPK-independent route, an effect later reframed against its pro-tumor stromal roles.","evidence":"Inducible/constitutive overexpression in tumor cell lines, Western blot, tumorigenicity assays","pmids":["12135612"],"confidence":"Medium","gaps":["Mechanism of p21 transcriptional induction undefined","Apparent contradiction with later pro-tumor findings unresolved"]},{"year":2009,"claim":"Connected GREM1's BMP antagonism to disease, showing allelic depletion preserves renal pSmad1/5/8 and attenuates diabetic kidney injury, establishing GREM1 as a pathological BMP antagonist in fibrosis.","evidence":"Grem1+/- mice in streptozotocin diabetes, pSmad and fibrosis-marker readouts","pmids":["19401426"],"confidence":"High","gaps":["Cell-type source of pathogenic Grem1 not pinpointed","Upstream induction signal unaddressed here"]},{"year":2011,"claim":"Placed GREM1 in a defined developmental hierarchy (Six1→Grem1→BMP4) required for ureteric bud branching, generalizing its BMP-antagonist role to kidney morphogenesis.","evidence":"Six1 knockout mice, GREM1 protein rescue, Six1/Bmp4 double-mutant epistasis, kidney rudiment culture","pmids":["21281623"],"confidence":"High","gaps":["Direct transcriptional link Six1→Grem1 not shown","Restricted to renal development"]},{"year":2012,"claim":"Showed GREM1 binds cancer cells and drives migration, invasion, and EMT independently of BMP2/4/7 and VEGFR2, reinforcing a BMP-independent pro-tumor signaling arm.","evidence":"Cell binding, neutralizing antibody blocking, wound-healing/invasion assays, E-cadherin staining","pmids":["22514712"],"confidence":"Medium","gaps":["Receptor mediating this binding not identified","Single lab in vitro"]},{"year":2015,"claim":"Identified VEGFR2 as a direct GREM1 receptor driving NF-κB-mediated renal inflammation independently of BMP antagonism, giving the proangiogenic/inflammatory arm a defined receptor.","evidence":"Recombinant gremlin in vivo/in vitro, VEGFR2 binding and kinase inhibition, NF-κB and histology","pmids":["25810250"],"confidence":"High","gaps":["Stoichiometry of GREM1-VEGFR2 interaction undefined","Relationship to BMP-binding interface unmapped"]},{"year":2014,"claim":"Demonstrated that aberrant epithelial GREM1 disrupts the intestinal BMP gradient to confer stem-like properties on Lgr5-negative progenitors, defining a mechanism for GREM1-driven cancer initiation.","evidence":"HMPS patient tissue, mouse epithelial overexpression, BMP gradient mapping, Lgr5 lineage tracing","pmids":["25419707"],"confidence":"High","gaps":["Quantitative BMP threshold for reprogramming not defined","Niche position dependence partly unresolved"]},{"year":2015,"claim":"Established GREM1 as a marker and functional requirement of skeletal/intestinal reticular stem cell populations, linking its niche-level BMP attenuation to multilineage stem cell maintenance.","evidence":"Grem1-Cre fate-mapping, clonal/transplantation assays, bone development and fracture-repair models","pmids":["25594183"],"confidence":"High","gaps":["Whether Grem1 protein vs. Grem1+ cell is required separable only partly","Molecular niche signals upstream unclear"]},{"year":2016,"claim":"Provided the structural and biophysical basis of inhibition, showing GREM1 is a DAN-family dimer forming higher-order oligomers with BMP-2 by a mechanism distinct from Noggin/Chordin.","evidence":"X-ray crystallography, biolayer interferometry, BMP-2 mutagenesis","pmids":["27036124"],"confidence":"High","gaps":["Structure of the GREM1-BMP complex not solved","Structural basis of BMP-independent receptor binding unknown"]},{"year":2018,"claim":"Extended BMP-independent signaling by showing GREM1 activates Notch (Jagged-1, N1ICD, hes-1/hey-1) linked to NF-κB renal inflammation, broadening the downstream effector repertoire.","evidence":"Tubular cell culture and in vivo gremlin injection, γ-secretase (DAPT) blockade, Western blot","pmids":["29720422"],"confidence":"Medium","gaps":["Direct receptor coupling GREM1 to Notch not defined","Single lab"]},{"year":2018,"claim":"Defined direct SLIT2-GREM1 binding as a node of negative cross-talk between SLIT-ROBO and BMP-Gremlin pathways, with BMP/SMAD4 repressing SLIT2.","evidence":"Direct binding, SLIT2-ROBO2 neuron assay, BMP assays in myoblasts/fibroblasts, promoter and SMAD4 knockdown","pmids":["29317497"],"confidence":"High","gaps":["Physiological context of this cross-talk in vivo unclear","Stoichiometry of SLIT2-GREM1 complex unmapped"]},{"year":2020,"claim":"Identified αvβ3 integrin as the receptor mediating GREM1-driven survival, proliferation, and invasion in synoviocytes via Erk/Akt/Bcl2, assigning a receptor to the integrin-engaging arm.","evidence":"siRNA, recombinant GREM1, αvβ3 neutralizing antibody, signaling Western blots and functional assays","pmids":["26834210"],"confidence":"Medium","gaps":["Single lab, RA-FLS context","Direct GREM1-integrin binding not structurally defined"]},{"year":2020,"claim":"Showed GREM1 activates VEGFR2-Akt-mTORC2 in RPE cells to drive proliferation, migration, and VEGF production, refining the receptor-coupled signaling mechanism.","evidence":"SU5416, VEGFR2/Rictor/Sin1 knockdowns, p-Akt/mTORC2 Western blots, functional assays","pmids":["27894090"],"confidence":"Medium","gaps":["Single lab","Cross-talk with BMP arm not assessed"]},{"year":2020,"claim":"Demonstrated that inducible Grem1 deletion in adult mice causes fatal enteropathy and bone marrow failure, proving an essential homeostatic requirement in epithelial renewal and hematopoiesis.","evidence":"Inducible conditional Grem1 knockout, histopathology, proliferation and marrow cellularity","pmids":["32297672"],"confidence":"High","gaps":["Whether phenotype is fully BMP-dependent not dissected","Cellular source driving lethality not isolated"]},{"year":2021,"claim":"Showed stromal Grem1-mediated BMP attenuation is obligatory but submaximal for regenerative stem-cell reprogramming after intestinal injury, refining its role in tissue regeneration.","evidence":"Transgenic autocrine Bmp4 and Grem1 deletion/overexpression mice, spatial BMP mapping in human and mouse","pmids":["33819486"],"confidence":"High","gaps":["Quantitative interplay with YAP/TAZ not fully resolved","Fibroblast subpopulation specificity partly open"]},{"year":2021,"claim":"Identified Grem1+ fibroblastic reticular cells as niche cells required for dendritic cell homeostasis and T-cell immunity, extending GREM1+ stromal niche function to immunity.","evidence":"Human/mouse scRNA-seq, Grem1-CreERT2 depletion, flow cytometry, T-cell immunity assays","pmids":["33903764"],"confidence":"High","gaps":["Whether Grem1 protein itself is the mediator vs. cell identity not separated","Receptor on cDCs undefined"]},{"year":2019,"claim":"Established a TGF-β→CAF-Grem1→BMP/SMAD axis driving breast cancer stemness, EMT, and dissemination, integrating stromal regulation with tumor cell phenotype.","evidence":"In situ hybridization, recombinant protein, SMAD assays, functional assays, zebrafish xenograft","pmids":["31533776"],"confidence":"Medium","gaps":["Single lab","Direct receptor on tumor cells not defined here"]},{"year":2020,"claim":"Linked GREM1 to metastatic signaling through STAT3-driven MMP13 transcription, adding a downstream transcriptional effector for its pro-metastatic activity.","evidence":"Knockdown/overexpression, orthotopic mouse model, STAT3 and MMP13 readouts","pmids":["33287358"],"confidence":"Medium","gaps":["Receptor upstream of STAT3 not identified","Single lab"]},{"year":2014,"claim":"Showed GREM1 is a direct transcriptional target of CDX2 and the Wnt effector TCF7L2 at a CRC risk allele, mechanistically connecting genetic risk to elevated GREM1 and tumor burden.","evidence":"Enhancer reporter, allele-specific CDX2/TCF7L2 binding, CDX2 overexpression, ApcMin dosage model","pmids":["25131200"],"confidence":"High","gaps":["Tissue-specificity of enhancer activity in vivo only partly resolved"]},{"year":2022,"claim":"Demonstrated bidirectionally (KO and OE in established PDAC) that paracrine Grem1 suppresses Snail/Slug to maintain epithelial identity and tumor cell heterogeneity, a striking cell-fate stabilizing role.","evidence":"Conditional Grem1 KO and OE in mouse PDAC, time-course fate analysis, human validation","pmids":["35768509"],"confidence":"High","gaps":["Receptor mediating epithelial response not defined","Whether purely BMP-mediated not fully isolated"]},{"year":2022,"claim":"Defined GREM1/ISLR as antagonistic CAF-derived regulators of stromal BMP signaling in CRC, with GREM1 neutralization or ISLR delivery suppressing tumor growth and promoting stem-cell differentiation.","evidence":"Human CRC RNA, in situ hybridization, tumoroid + neutralizing antibody, Islr overexpression, AAV8 in vivo","pmids":["33197448"],"confidence":"High","gaps":["Mechanism of FOXL1/TGF-β control of subpopulations partly open"]},{"year":2022,"claim":"Showed GREM1 marks bipotent articular cartilage progenitors whose depletion causes OA, with Foxo1 required for their survival and FGF18/FGFR3 promoting their expansion, defining a regenerative target in joint disease.","evidence":"Grem1-Cre lineage tracing, genetic ablation, Foxo1 conditional KO, FGF18 administration, transcriptomics","pmids":["37907525"],"confidence":"High","gaps":["Whether Grem1 protein vs. Grem1+ cell drives chondroprotection not separated"]},{"year":2022,"claim":"Implicated GREM1 across fibrotic and degenerative diseases through differential Smad balance, antagonizing protective BMP and modulating TGF-β/Smad2/3 in lung EndMT, disc apoptosis, ocular hypertension, and NASH senescence.","evidence":"Recombinant protein and knockdown studies, Smad phosphorylation, Smad3-KO epistasis, spheroid and in vivo models","pmids":["32145252","35440754","26284554","35995996","26141517"],"confidence":"Medium","gaps":["Receptor specificity for TGF-β/Smad2/3 effects not defined","Cross-tissue generalizability uncertain"]},{"year":null,"claim":"How GREM1's BMP-antagonist surface relates structurally to its BMP-independent receptor engagements (VEGFR2, αvβ3 integrin, SLIT2) and how a single secreted factor selects among these outputs in a given tissue remains unresolved.","evidence":"No structural model of GREM1 bound to VEGFR2 or integrin is available in the corpus","pmids":[],"confidence":"Low","gaps":["No structure of GREM1 with any non-BMP receptor","Determinants of context-dependent BMP-dependent vs. -independent signaling unknown","Reconciliation of tumor-suppressive vs. pro-tumor activities incomplete"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,1,16,15,8]},{"term_id":"GO:0140313","term_label":"molecular sequestering activity","supporting_discovery_ids":[0,16]},{"term_id":"GO:0048018","term_label":"receptor ligand activity","supporting_discovery_ids":[11,22]}],"localization":[{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[0,1,5]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[1]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[1]},{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[1]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,11,16,18,23]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[2,6,9,12,34]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[8,15,33,27,30]},{"term_id":"R-HSA-1474244","term_label":"Extracellular matrix organization","supporting_discovery_ids":[14,8]}],"complexes":[],"partners":["BMP2","BMP4","BMP7","VEGFR2","ITGAV","ITGB3","SLIT2","SLIT1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"O60565","full_name":"Gremlin-1","aliases":["Cell proliferation-inducing gene 2 protein","Cysteine knot superfamily 1, BMP antagonist 1","DAN domain family member 2","Down-regulated in Mos-transformed cells protein","Increased in high glucose protein 2","IHG-2"],"length_aa":184,"mass_kda":20.7,"function":"Cytokine that may play an important role during carcinogenesis and metanephric kidney organogenesis, as a BMP antagonist required for early limb outgrowth and patterning in maintaining the FGF4-SHH feedback loop. Down-regulates the BMP4 signaling in a dose-dependent manner (By similarity). Antagonist of BMP2; inhibits BMP2-mediated differentiation of osteoblasts (in vitro) (PubMed:27036124). Acts as inhibitor of monocyte chemotaxis. Can inhibit the growth or viability of normal cells but not transformed cells when is overexpressed (By similarity)","subcellular_location":"Secreted","url":"https://www.uniprot.org/uniprotkb/O60565/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GREM1","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GREM1","total_profiled":1310},"omim":[{"mim_id":"603054","title":"GREMLIN 1, DAN FAMILY BMP ANTAGONIST; GREM1","url":"https://www.omim.org/entry/603054"},{"mim_id":"601740","title":"MEIS HOMEOBOX 2; MEIS2","url":"https://www.omim.org/entry/601740"},{"mim_id":"601228","title":"POLYPOSIS SYNDROME, HEREDITARY MIXED, 1; HMPS1","url":"https://www.omim.org/entry/601228"},{"mim_id":"600725","title":"SONIC HEDGEHOG SIGNALING MOLECULE; SHH","url":"https://www.omim.org/entry/600725"},{"mim_id":"600483","title":"FIBROBLAST GROWTH FACTOR 8; FGF8","url":"https://www.omim.org/entry/600483"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"gallbladder","ntpm":105.6},{"tissue":"intestine","ntpm":59.9},{"tissue":"smooth muscle","ntpm":63.6},{"tissue":"vagina","ntpm":63.4}],"url":"https://www.proteinatlas.org/search/GREM1"},"hgnc":{"alias_symbol":["DRM","gremlin","DAND2","HMPS"],"prev_symbol":["CKTSF1B1","CRAC1"]},"alphafold":{"accession":"O60565","domains":[{"cath_id":"2.10.90.10","chopping":"85-180","consensus_level":"high","plddt":93.3897,"start":85,"end":180}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O60565","model_url":"https://alphafold.ebi.ac.uk/files/AF-O60565-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O60565-F1-predicted_aligned_error_v6.png","plddt_mean":73.5},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GREM1","jax_strain_url":"https://www.jax.org/strain/search?query=GREM1"},"sequence":{"accession":"O60565","fasta_url":"https://rest.uniprot.org/uniprotkb/O60565.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O60565/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O60565"}},"corpus_meta":[{"pmid":"25594183","id":"PMC_25594183","title":"Gremlin 1 identifies a skeletal stem cell with bone, cartilage, and reticular stromal potential.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/25594183","citation_count":543,"is_preprint":false},{"pmid":"12151602","id":"PMC_12151602","title":"Locus-specific control of asymmetric and CpNpG methylation by the DRM and CMT3 methyltransferase genes.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12151602","citation_count":415,"is_preprint":false},{"pmid":"14680640","id":"PMC_14680640","title":"Role of the DRM and CMT3 methyltransferases in RNA-directed DNA methylation.","date":"2003","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/14680640","citation_count":369,"is_preprint":false},{"pmid":"12808456","id":"PMC_12808456","title":"Gremlin is the BMP antagonist required for maintenance of Shh and Fgf signals during limb patterning.","date":"2003","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12808456","citation_count":295,"is_preprint":false},{"pmid":"10556075","id":"PMC_10556075","title":"The BMP antagonist Gremlin regulates outgrowth, chondrogenesis and programmed cell death in the developing limb.","date":"1999","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/10556075","citation_count":267,"is_preprint":false},{"pmid":"18084292","id":"PMC_18084292","title":"Common genetic variants at the CRAC1 (HMPS) locus on chromosome 15q13.3 influence colorectal cancer risk.","date":"2007","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18084292","citation_count":246,"is_preprint":false},{"pmid":"24855943","id":"PMC_24855943","title":"Molecular mechanism of action of plant DRM de novo DNA methyltransferases.","date":"2014","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/24855943","citation_count":240,"is_preprint":false},{"pmid":"25419707","id":"PMC_25419707","title":"Aberrant epithelial GREM1 expression initiates colonic tumorigenesis from cells outside the stem cell niche.","date":"2014","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25419707","citation_count":216,"is_preprint":false},{"pmid":"22561515","id":"PMC_22561515","title":"Hereditary mixed polyposis syndrome is caused by a 40-kb upstream duplication that leads to increased and ectopic expression of the BMP antagonist GREM1.","date":"2012","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22561515","citation_count":184,"is_preprint":false},{"pmid":"21655089","id":"PMC_21655089","title":"Multiple common susceptibility variants near BMP pathway loci GREM1, BMP4, and BMP2 explain part of the missing heritability of colorectal cancer.","date":"2011","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21655089","citation_count":182,"is_preprint":false},{"pmid":"33197448","id":"PMC_33197448","title":"The Balance of Stromal BMP Signaling Mediated by GREM1 and ISLR Drives Colorectal Carcinogenesis.","date":"2020","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/33197448","citation_count":131,"is_preprint":false},{"pmid":"31533776","id":"PMC_31533776","title":"Cancer-associated fibroblast-derived Gremlin 1 promotes breast cancer progression.","date":"2019","source":"Breast cancer research : BCR","url":"https://pubmed.ncbi.nlm.nih.gov/31533776","citation_count":130,"is_preprint":false},{"pmid":"30120709","id":"PMC_30120709","title":"LncRNA PVT1 Facilitates Tumorigenesis and Progression of Glioma via Regulation of MiR-128-3p/GREM1 Axis and BMP Signaling Pathway.","date":"2018","source":"Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/30120709","citation_count":127,"is_preprint":false},{"pmid":"10722723","id":"PMC_10722723","title":"Biosynthesis, post-translation modification, and functional characterization of Drm/Gremlin.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10722723","citation_count":122,"is_preprint":false},{"pmid":"15957132","id":"PMC_15957132","title":"Expression of gremlin, a bone morphogenetic protein antagonist, in human diabetic nephropathy.","date":"2005","source":"American journal of kidney diseases : the official journal of the National Kidney Foundation","url":"https://pubmed.ncbi.nlm.nih.gov/15957132","citation_count":120,"is_preprint":false},{"pmid":"17077323","id":"PMC_17077323","title":"Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor.","date":"2006","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/17077323","citation_count":114,"is_preprint":false},{"pmid":"22576962","id":"PMC_22576962","title":"Gremlin 1, frizzled-related protein, and Dkk-1 are key regulators of human articular cartilage homeostasis.","date":"2012","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/22576962","citation_count":114,"is_preprint":false},{"pmid":"9234736","id":"PMC_9234736","title":"Identification of drm, a novel gene whose expression is suppressed in transformed cells and which can inhibit growth of normal but not transformed cells in culture.","date":"1997","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9234736","citation_count":107,"is_preprint":false},{"pmid":"27910957","id":"PMC_27910957","title":"miR-27a attenuates adipogenesis and promotes osteogenesis in steroid-induced rat BMSCs by targeting PPARγ and GREM1.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27910957","citation_count":105,"is_preprint":false},{"pmid":"17980714","id":"PMC_17980714","title":"Co-regulation of Gremlin and Notch signalling in diabetic nephropathy.","date":"2007","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/17980714","citation_count":92,"is_preprint":false},{"pmid":"35440754","id":"PMC_35440754","title":"Grem1 accelerates nucleus pulposus cell apoptosis and intervertebral disc degeneration by inhibiting TGF-β-mediated Smad2/3 phosphorylation.","date":"2022","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35440754","citation_count":91,"is_preprint":false},{"pmid":"33903764","id":"PMC_33903764","title":"Gremlin 1+ fibroblastic niche maintains dendritic cell homeostasis in lymphoid tissues.","date":"2021","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33903764","citation_count":80,"is_preprint":false},{"pmid":"16234815","id":"PMC_16234815","title":"DNA methylation-associated inactivation of TGFbeta-related genes DRM/Gremlin, RUNX3, and HPP1 in human cancers.","date":"2005","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/16234815","citation_count":71,"is_preprint":false},{"pmid":"12696020","id":"PMC_12696020","title":"An ancestral Ashkenazi haplotype at the HMPS/CRAC1 locus on 15q13-q14 is associated with hereditary mixed polyposis syndrome.","date":"2003","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12696020","citation_count":71,"is_preprint":false},{"pmid":"35768509","id":"PMC_35768509","title":"GREM1 is required to maintain cellular heterogeneity in pancreatic cancer.","date":"2022","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/35768509","citation_count":69,"is_preprint":false},{"pmid":"24286177","id":"PMC_24286177","title":"GREM1, FRZB and DKK1 mRNA levels correlate with osteoarthritis and are regulated by osteoarthritis-associated factors.","date":"2013","source":"Arthritis research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/24286177","citation_count":69,"is_preprint":false},{"pmid":"35995996","id":"PMC_35995996","title":"BMP4 and Gremlin 1 regulate hepatic cell senescence during clinical progression of NAFLD/NASH.","date":"2022","source":"Nature metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/35995996","citation_count":68,"is_preprint":false},{"pmid":"26968009","id":"PMC_26968009","title":"Meta-analysis Reveals Genome-Wide Significance at 15q13 for Nonsyndromic Clefting of Both the Lip and the Palate, and Functional Analyses Implicate GREM1 As a Plausible Causative Gene.","date":"2016","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26968009","citation_count":68,"is_preprint":false},{"pmid":"19401426","id":"PMC_19401426","title":"Allelic depletion of grem1 attenuates diabetic kidney disease.","date":"2009","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/19401426","citation_count":67,"is_preprint":false},{"pmid":"27036124","id":"PMC_27036124","title":"Structure of Gremlin-1 and analysis of its interaction with BMP-2.","date":"2016","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/27036124","citation_count":61,"is_preprint":false},{"pmid":"19574532","id":"PMC_19574532","title":"Role of gremlin in the lung: development and disease.","date":"2009","source":"American journal of respiratory cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19574532","citation_count":60,"is_preprint":false},{"pmid":"15528323","id":"PMC_15528323","title":"Cutting edge: bone morphogenetic protein antagonists Drm/Gremlin and Dan interact with Slits and act as negative regulators of monocyte chemotaxis.","date":"2004","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/15528323","citation_count":60,"is_preprint":false},{"pmid":"16525031","id":"PMC_16525031","title":"Mapping of hereditary mixed polyposis syndrome (HMPS) to chromosome 10q23 by genomewide high-density single nucleotide polymorphism (SNP) scan and identification of BMPR1A loss of function.","date":"2006","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16525031","citation_count":57,"is_preprint":false},{"pmid":"16989805","id":"PMC_16989805","title":"Regulation of Gremlin expression in the posterior limb bud.","date":"2006","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/16989805","citation_count":56,"is_preprint":false},{"pmid":"33287358","id":"PMC_33287358","title":"Gremlin-1 Promotes Metastasis of Breast Cancer Cells by Activating STAT3-MMP13 Signaling Pathway.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33287358","citation_count":54,"is_preprint":false},{"pmid":"25153376","id":"PMC_25153376","title":"Bone morphogenetic protein antagonist gremlin-1 regulates colon cancer progression.","date":"2015","source":"Biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25153376","citation_count":54,"is_preprint":false},{"pmid":"10894942","id":"PMC_10894942","title":"DRM/GREMLIN (CKTSF1B1) maps to human chromosome 15 and is highly expressed in adult and fetal brain.","date":"2000","source":"Cytogenetics and cell genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10894942","citation_count":53,"is_preprint":false},{"pmid":"22514712","id":"PMC_22514712","title":"Gremlin-1 induces BMP-independent tumor cell proliferation, migration, and invasion.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22514712","citation_count":53,"is_preprint":false},{"pmid":"25810250","id":"PMC_25810250","title":"Gremlin regulates renal inflammation via the vascular endothelial growth factor receptor 2 pathway.","date":"2015","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/25810250","citation_count":52,"is_preprint":false},{"pmid":"12135612","id":"PMC_12135612","title":"Drm/Gremlin transcriptionally activates p21(Cip1) via a novel mechanism and inhibits neoplastic transformation.","date":"2002","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/12135612","citation_count":48,"is_preprint":false},{"pmid":"12386293","id":"PMC_12386293","title":"Gremlin: an example of the re-emergence of developmental programmes in diabetic nephropathy.","date":"2002","source":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association","url":"https://pubmed.ncbi.nlm.nih.gov/12386293","citation_count":48,"is_preprint":false},{"pmid":"33819486","id":"PMC_33819486","title":"Bone Morphogenetic Protein Pathway Antagonism by Grem1 Regulates Epithelial Cell Fate in Intestinal Regeneration.","date":"2021","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/33819486","citation_count":46,"is_preprint":false},{"pmid":"21589891","id":"PMC_21589891","title":"Chromosome-biased binding and gene regulation by the Caenorhabditis elegans DRM complex.","date":"2011","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21589891","citation_count":46,"is_preprint":false},{"pmid":"17403698","id":"PMC_17403698","title":"Expression of gremlin, a bone morphogenetic protein antagonist, in glomerular crescents of pauci-immune glomerulonephritis.","date":"2007","source":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association","url":"https://pubmed.ncbi.nlm.nih.gov/17403698","citation_count":45,"is_preprint":false},{"pmid":"18086474","id":"PMC_18086474","title":"Gremlin promotes vascular smooth muscle cell proliferation and migration.","date":"2007","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/18086474","citation_count":44,"is_preprint":false},{"pmid":"26141517","id":"PMC_26141517","title":"Gremlin is a key pro-fibrogenic factor in chronic pancreatitis.","date":"2015","source":"Journal of molecular medicine (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/26141517","citation_count":43,"is_preprint":false},{"pmid":"26416033","id":"PMC_26416033","title":"GREMLIN 2 Mutations and Dental Anomalies.","date":"2015","source":"Journal of dental research","url":"https://pubmed.ncbi.nlm.nih.gov/26416033","citation_count":42,"is_preprint":false},{"pmid":"25131200","id":"PMC_25131200","title":"A polymorphic enhancer near GREM1 influences bowel cancer risk through differential CDX2 and TCF7L2 binding.","date":"2014","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/25131200","citation_count":42,"is_preprint":false},{"pmid":"26493165","id":"PMC_26493165","title":"GREM1 and POLE variants in hereditary colorectal cancer syndromes.","date":"2015","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/26493165","citation_count":38,"is_preprint":false},{"pmid":"20150533","id":"PMC_20150533","title":"A GREM1 gene variant associates with diabetic nephropathy.","date":"2010","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/20150533","citation_count":37,"is_preprint":false},{"pmid":"28346486","id":"PMC_28346486","title":"GREM1 is expressed in the cancer-associated myofibroblasts of basal cell carcinomas.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/28346486","citation_count":35,"is_preprint":false},{"pmid":"24614542","id":"PMC_24614542","title":"Roles of Gremlin 1 and Gremlin 2 in regulating ovarian primordial to primary follicle transition.","date":"2014","source":"Reproduction (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/24614542","citation_count":35,"is_preprint":false},{"pmid":"37907525","id":"PMC_37907525","title":"Loss of Grem1-lineage chondrogenic progenitor cells causes osteoarthritis.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/37907525","citation_count":34,"is_preprint":false},{"pmid":"29720422","id":"PMC_29720422","title":"Gremlin activates the Notch pathway linked to renal inflammation.","date":"2018","source":"Clinical science (London, England : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/29720422","citation_count":33,"is_preprint":false},{"pmid":"30426548","id":"PMC_30426548","title":"Knockdown GREM1 suppresses cell growth, angiogenesis, and epithelial-mesenchymal transition in colon cancer.","date":"2018","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30426548","citation_count":32,"is_preprint":false},{"pmid":"14568103","id":"PMC_14568103","title":"The Drm-Bowl-Lin relief-of-repression hierarchy controls fore- and hindgut patterning and morphogenesis.","date":"2003","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/14568103","citation_count":31,"is_preprint":false},{"pmid":"26284554","id":"PMC_26284554","title":"Gremlin Induces Ocular Hypertension in Mice Through Smad3-Dependent Signaling.","date":"2015","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/26284554","citation_count":30,"is_preprint":false},{"pmid":"35883579","id":"PMC_35883579","title":"Gremlin-1 Promotes Colorectal Cancer Cell Metastasis by Activating ATF6 and Inhibiting ATF4 Pathways.","date":"2022","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/35883579","citation_count":29,"is_preprint":false},{"pmid":"27448692","id":"PMC_27448692","title":"GREM1, EGFR, and HAS2; the oocyte competence markers for improved buffalo embryo production in vitro.","date":"2016","source":"Theriogenology","url":"https://pubmed.ncbi.nlm.nih.gov/27448692","citation_count":29,"is_preprint":false},{"pmid":"34752967","id":"PMC_34752967","title":"He-Chan Pian inhibits the metastasis of non-small cell lung cancer via the miR-205-5p-mediated regulation of the GREM1/Rap1 signaling pathway.","date":"2021","source":"Phytomedicine : international journal of phytotherapy and phytopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/34752967","citation_count":28,"is_preprint":false},{"pmid":"31234714","id":"PMC_31234714","title":"Gremlin is a potential target for posterior capsular opacification.","date":"2019","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/31234714","citation_count":28,"is_preprint":false},{"pmid":"27385727","id":"PMC_27385727","title":"BMP signalling in human fetal ovary somatic cells is modulated in a gene-specific fashion by GREM1 and GREM2.","date":"2016","source":"Molecular human reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/27385727","citation_count":28,"is_preprint":false},{"pmid":"21281623","id":"PMC_21281623","title":"Six1 regulates Grem1 expression in the metanephric mesenchyme to initiate branching morphogenesis.","date":"2011","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/21281623","citation_count":28,"is_preprint":false},{"pmid":"29228689","id":"PMC_29228689","title":"Gremlin-1 is a key regulator of the invasive cell phenotype in mesothelioma.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/29228689","citation_count":28,"is_preprint":false},{"pmid":"31143092","id":"PMC_31143092","title":"Overexpression of mircoRNA-137 inhibits cervical cancer cell invasion, migration and epithelial-mesenchymal transition by suppressing the TGF-β/smad pathway via binding to GREM1.","date":"2019","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/31143092","citation_count":28,"is_preprint":false},{"pmid":"19303394","id":"PMC_19303394","title":"Bone morphogenetic protein-7 and Gremlin: New emerging therapeutic targets for diabetic nephropathy.","date":"2009","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/19303394","citation_count":27,"is_preprint":false},{"pmid":"35933397","id":"PMC_35933397","title":"GREM1/PPP2R3A expression in heterogeneous fibroblasts initiates pulmonary fibrosis.","date":"2022","source":"Cell & bioscience","url":"https://pubmed.ncbi.nlm.nih.gov/35933397","citation_count":26,"is_preprint":false},{"pmid":"27713170","id":"PMC_27713170","title":"Gremlin inhibits UV-induced skin cell damages via activating VEGFR2-Nrf2 signaling.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27713170","citation_count":26,"is_preprint":false},{"pmid":"33360372","id":"PMC_33360372","title":"Circ_DHRS3 positively regulates GREM1 expression by competitively targeting miR-183-5p to modulate IL-1β-administered chondrocyte proliferation, apoptosis and ECM degradation.","date":"2020","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/33360372","citation_count":26,"is_preprint":false},{"pmid":"26834210","id":"PMC_26834210","title":"GREM1 Is a Key Regulator of Synoviocyte Hyperplasia and Invasiveness.","date":"2016","source":"The Journal of rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/26834210","citation_count":25,"is_preprint":false},{"pmid":"32151168","id":"PMC_32151168","title":"GREM1 inhibits osteogenic differentiation, senescence and BMP transcription of adipose-derived stem cells.","date":"2020","source":"Connective tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/32151168","citation_count":23,"is_preprint":false},{"pmid":"15272379","id":"PMC_15272379","title":"Drm/Gremlin, a BMP antagonist, defines the interbud region during feather development.","date":"2004","source":"The International journal of developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/15272379","citation_count":23,"is_preprint":false},{"pmid":"22160428","id":"PMC_22160428","title":"Impaired gremlin 1 (GREM1) expression in cumulus cells in young women with diminished ovarian reserve (DOR).","date":"2011","source":"Journal of assisted reproduction and genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22160428","citation_count":22,"is_preprint":false},{"pmid":"30272371","id":"PMC_30272371","title":"Overexpression of Gremlin 1 by sonic hedgehog signaling promotes pancreatic cancer progression.","date":"2018","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/30272371","citation_count":22,"is_preprint":false},{"pmid":"28992340","id":"PMC_28992340","title":"Gremlin and renal diseases: ready to jump the fence to clinical utility?","date":"2018","source":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association","url":"https://pubmed.ncbi.nlm.nih.gov/28992340","citation_count":21,"is_preprint":false},{"pmid":"32141512","id":"PMC_32141512","title":"DHA inhibits Gremlin-1-induced epithelial-to-mesenchymal transition via ERK suppression in human breast cancer cells.","date":"2020","source":"Bioscience reports","url":"https://pubmed.ncbi.nlm.nih.gov/32141512","citation_count":21,"is_preprint":false},{"pmid":"30569497","id":"PMC_30569497","title":"Cenani-Lenz syndrome and other related syndactyly disorders due to variants in LRP4, GREM1/FMN1, and APC: Insight into the pathogenesis and the relationship to polyposis through the WNT and BMP antagonistic pathways.","date":"2018","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/30569497","citation_count":20,"is_preprint":false},{"pmid":"27894090","id":"PMC_27894090","title":"Gremlin promotes retinal pigmentation epithelial (RPE) cell proliferation, migration and VEGF production via activating VEGFR2-Akt-mTORC2 signaling.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27894090","citation_count":20,"is_preprint":false},{"pmid":"28260028","id":"PMC_28260028","title":"Gremlin-1 suppression increases BMP-2-induced osteogenesis of human mesenchymal stem cells.","date":"2017","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/28260028","citation_count":20,"is_preprint":false},{"pmid":"35216203","id":"PMC_35216203","title":"Gremlin-1 and BMP-4 Overexpressed in Osteoarthritis Drive an Osteochondral-Remodeling Program in Osteoblasts and Hypertrophic Chondrocytes.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35216203","citation_count":19,"is_preprint":false},{"pmid":"11231088","id":"PMC_11231088","title":"Expression pattern of the drm/gremlin gene during chicken embryonic development.","date":"2001","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/11231088","citation_count":19,"is_preprint":false},{"pmid":"29317497","id":"PMC_29317497","title":"Identification of direct negative cross-talk between the SLIT2 and bone morphogenetic protein-Gremlin signaling pathways.","date":"2018","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29317497","citation_count":19,"is_preprint":false},{"pmid":"33097188","id":"PMC_33097188","title":"Gremlin-1 activates Akt/STAT3 signaling, which increases the glycolysis rate in breast cancer cells.","date":"2020","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/33097188","citation_count":19,"is_preprint":false},{"pmid":"38970064","id":"PMC_38970064","title":"miR-455/GREM1 axis promotes colorectal cancer progression and liver metastasis by affecting PI3K/AKT pathway and inducing M2 macrophage polarization.","date":"2024","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/38970064","citation_count":18,"is_preprint":false},{"pmid":"18640997","id":"PMC_18640997","title":"Isolation and expression analysis of genes encoding MET, CMT, and DRM methyltransferases in oil palm (Elaeis guineensis Jacq.) in relation to the 'mantled' somaclonal variation.","date":"2008","source":"Journal of experimental botany","url":"https://pubmed.ncbi.nlm.nih.gov/18640997","citation_count":18,"is_preprint":false},{"pmid":"32145252","id":"PMC_32145252","title":"Gremlin-1 is a key regulator of endothelial-to-mesenchymal transition in human pulmonary artery endothelial cells.","date":"2020","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/32145252","citation_count":18,"is_preprint":false},{"pmid":"15919833","id":"PMC_15919833","title":"Differential expression of the peripheral benzodiazepine receptor and gremlin during adipogenesis.","date":"2005","source":"Obesity research","url":"https://pubmed.ncbi.nlm.nih.gov/15919833","citation_count":18,"is_preprint":false},{"pmid":"31525341","id":"PMC_31525341","title":"GREM1 overexpression inhibits proliferation, migration and angiogenesis of osteosarcoma.","date":"2019","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/31525341","citation_count":17,"is_preprint":false},{"pmid":"35203511","id":"PMC_35203511","title":"Insights into the Role of Gremlin-1, a Bone Morphogenic Protein Antagonist, in Cancer Initiation and Progression.","date":"2022","source":"Biomedicines","url":"https://pubmed.ncbi.nlm.nih.gov/35203511","citation_count":17,"is_preprint":false},{"pmid":"32750294","id":"PMC_32750294","title":"Vital Roles of Gremlin-1 in Pulmonary Arterial Hypertension Induced by Systemic-to-Pulmonary Shunts.","date":"2020","source":"Journal of the American Heart Association","url":"https://pubmed.ncbi.nlm.nih.gov/32750294","citation_count":17,"is_preprint":false},{"pmid":"36155165","id":"PMC_36155165","title":"Role of gremlin-1 in the pathophysiology of the adipose tissues.","date":"2022","source":"Cytokine & growth factor reviews","url":"https://pubmed.ncbi.nlm.nih.gov/36155165","citation_count":16,"is_preprint":false},{"pmid":"37615860","id":"PMC_37615860","title":"GREM1 signaling in cancer: tumor promotor and suppressor?","date":"2023","source":"Journal of cell communication and signaling","url":"https://pubmed.ncbi.nlm.nih.gov/37615860","citation_count":16,"is_preprint":false},{"pmid":"32297672","id":"PMC_32297672","title":"Gremlin 1 depletion in vivo causes severe enteropathy and bone marrow failure.","date":"2020","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/32297672","citation_count":16,"is_preprint":false},{"pmid":"33107676","id":"PMC_33107676","title":"Role of miR-218-GREM1 axis in epithelial-mesenchymal transition of oral squamous cell carcinoma: An in vivo and vitro study based on microarray data.","date":"2020","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33107676","citation_count":16,"is_preprint":false},{"pmid":"35005111","id":"PMC_35005111","title":"Pancreatic stromal Gremlin 1 expression during pancreatic tumorigenesis.","date":"2020","source":"Genes & diseases","url":"https://pubmed.ncbi.nlm.nih.gov/35005111","citation_count":15,"is_preprint":false},{"pmid":"25992589","id":"PMC_25992589","title":"GREM1 germline mutation screening in Ashkenazi Jewish patients with familial colorectal cancer.","date":"2015","source":"Genetics research","url":"https://pubmed.ncbi.nlm.nih.gov/25992589","citation_count":15,"is_preprint":false},{"pmid":"34993960","id":"PMC_34993960","title":"Gremlin aggravates periodontitis via activation of the nuclear factor-kappa B signaling pathway.","date":"2022","source":"Journal of periodontology","url":"https://pubmed.ncbi.nlm.nih.gov/34993960","citation_count":15,"is_preprint":false},{"pmid":"27929199","id":"PMC_27929199","title":"Platelets as a novel source of Gremlin-1: Implications for thromboinflammation.","date":"2016","source":"Thrombosis and haemostasis","url":"https://pubmed.ncbi.nlm.nih.gov/27929199","citation_count":15,"is_preprint":false},{"pmid":"19028757","id":"PMC_19028757","title":"Expression of gremlin, a bone morphogenetic protein antagonist,is associated with vascular calcification in uraemia.","date":"2008","source":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association","url":"https://pubmed.ncbi.nlm.nih.gov/19028757","citation_count":14,"is_preprint":false},{"pmid":"37496731","id":"PMC_37496731","title":"TAF15 regulates the BRD4/GREM1 axis and activates the gremlin-1-NF-κB pathway to promote OA progression.","date":"2023","source":"Regenerative therapy","url":"https://pubmed.ncbi.nlm.nih.gov/37496731","citation_count":13,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":53137,"output_tokens":9694,"usd":0.152411,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":19960,"output_tokens":7910,"usd":0.148775,"stage2_stop_reason":"end_turn"},"total_usd":0.301186,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"Gremlin is a member of the DAN family of BMP antagonists that binds and blocks BMP2, BMP4, and BMP7; exogenous recombinant Gremlin in the developing avian limb controls outgrowth, restricts programmed cell death, confines chondrogenesis, and regulates interdigital tissue regression, all mediated by neutralization of BMP signaling.\",\n      \"method\": \"In vivo administration of recombinant protein in chick embryo limb bud; expression analysis by in situ hybridization\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct in vivo functional rescue/gain-of-function with defined cellular phenotypes (outgrowth, apoptosis, chondrogenesis), replicated across multiple developmental stages and independently consistent with biochemical data on BMP binding\",\n      \"pmids\": [\"10556075\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Drm/Gremlin is synthesized as a secreted glycoprotein that exists in both glycosylated and non-glycosylated forms; both undergo phosphorylation. The protein is present on the external cell surface and within the ER/Golgi. Both cell-associated and secreted forms bind 125I-BMP-4 and antagonize BMP signaling.\",\n      \"method\": \"Metabolic labeling, SDS-PAGE, confocal immunofluorescence microscopy, 125I-BMP-4 binding assay, BMP signaling reporter assay\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — multiple orthogonal biochemical methods (radiolabeled ligand binding, metabolic labeling, confocal localization, functional signaling assay) in a single focused study\",\n      \"pmids\": [\"10722723\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Gremlin (Cktsf1b1) is the principal BMP antagonist required for early limb outgrowth and patterning in mice; its loss interrupts the positive feedback loop between the zone of polarizing activity (ZPA/Shh) and the apical ectodermal ridge (AER/Fgf), resulting in abnormal skeletal patterning. The gremlin mutation is allelic to the limb deformity (ld) mutation.\",\n      \"method\": \"Mouse knockout/genetic mutation, in vivo skeletal phenotyping, genetic epistasis (allele complementation)\",\n      \"journal\": \"Nature Genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — loss-of-function mouse genetics with clear pathway epistasis, allelic complementation with independent ld mutation\",\n      \"pmids\": [\"12808456\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Drm/Gremlin overexpression in tumor-derived cell lines (Daoy, Saos-2) inhibits tumorigenesis, increases p21(Cip1) protein levels via a p53- and MAP kinase-independent transcriptional mechanism, and reduces phospho-p42/44 MAP kinase levels.\",\n      \"method\": \"Ecdysone-inducible and constitutive overexpression in tumor cell lines; Western blot for p21(Cip1) and phospho-p42/44 MAPK; tumorigenicity assays\",\n      \"journal\": \"Biochemical and Biophysical Research Communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — gain-of-function in multiple cell lines with two orthogonal readouts (p21 induction, MAPK phosphorylation), single lab\",\n      \"pmids\": [\"12135612\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Drm/Gremlin and Dan physically interact with Slit1 and Slit2 proteins; this binding depends on glycosylation of Drm and is not competed by BMPs. Drm and Dan function as inhibitors of monocyte chemotaxis induced by SDF-1α or fMLP; Dan's inhibition is not due to blocking SDF-1α binding to its receptor.\",\n      \"method\": \"Co-immunoprecipitation/pulldown, monocyte chemotaxis assays, competitive binding assays\",\n      \"journal\": \"Journal of Immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — direct binding demonstrated by pulldown plus functional chemotaxis assay, with mechanistic dissection ruling out one mechanism; single lab\",\n      \"pmids\": [\"15528323\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Drm/Gremlin is a proangiogenic factor expressed by endothelium that stimulates endothelial cell migration and invasion in fibrin and collagen gels, binds with high affinity to endothelial cells, triggers tyrosine phosphorylation of intracellular signaling proteins, and induces neovascularization in the chick chorioallantoic membrane. This proangiogenic activity is BMP4-independent: BMP4 does not affect Drm/Gremlin–endothelium interaction.\",\n      \"method\": \"Protein purification from conditioned medium using endothelial sprouting assay; recombinant protein binding studies; in vitro migration/invasion assays; CAM neovascularization assay; tyrosine phosphorylation Western blot\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — protein purified to homogeneity from conditioned medium, multiple orthogonal functional assays (migration, invasion, in vivo CAM), BMP-independence demonstrated\",\n      \"pmids\": [\"17077323\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"BMP activity is necessary and sufficient for induction of Gremlin expression in the posterior limb bud (low BMP2 upregulates Gremlin; high BMP2 downregulates it). Shh activity is required to exclude Gremlin from the posterior limb domain, thereby terminating the Shh-Fgf4 signaling loop.\",\n      \"method\": \"Bead implantation assays (BMP2, Noggin beads in chick limb), oligozeugodactyly mutant limbs lacking Shh, cyclopamine Shh blockade, in vivo limb mesenchyme cultures\",\n      \"journal\": \"Developmental Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple gain- and loss-of-function experiments in vivo and ex vivo, epistasis with Shh established via genetic and pharmacological approaches\",\n      \"pmids\": [\"16989805\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Gremlin promotes vascular smooth muscle cell (VSMC) proliferation and migration by blocking BMP signaling; stable overexpression blocks BMP-induced reduction of DNA synthesis, accelerates cell cycle progression through p27(kip1) down-regulation, and increases migration. Gremlin expression in VSMCs is induced by angiotensin II, TGF-β1, and PDGF, and is elevated in neointima of balloon-injured carotid arteries.\",\n      \"method\": \"Stable overexpression, gene silencing (siRNA), DNA synthesis assay, cell counting, cell cycle analysis, migration assay, in vivo balloon injury model, Western blot\",\n      \"journal\": \"Journal of Molecular and Cellular Cardiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — reciprocal gain- and loss-of-function with defined cellular readouts; single lab\",\n      \"pmids\": [\"18086474\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Allelic depletion of grem1 in streptozotocin-diabetic mice (grem1+/-) attenuates diabetic kidney disease: pSmad1/5/8 (BMP signaling) is maintained in grem1+/- kidneys (unlike wild-type diabetic kidneys), and markers of renal damage (fibronectin, CTGF, glomerular basement membrane thickening, microalbuminuria) are reduced, placing grem1 as a BMP antagonist driving renal injury.\",\n      \"method\": \"Grem1 heterozygous knockout mouse, streptozotocin diabetes model, immunohistochemistry, Western blot for pSmad1/5/8 and fibrosis markers, microalbuminuria measurement\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic loss-of-function in disease model with multiple orthogonal readouts including pathway-level mechanistic marker (pSmad); single lab\",\n      \"pmids\": [\"19401426\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Six1 regulates Grem1 expression in the metanephric mesenchyme (MM) to initiate ureteric bud branching morphogenesis: Six1-/- mice lack Grem1 expression in the MM, causing failure of ampulla formation. Restoring GREM1 protein to Six1-/- kidney rudiments rescues branching. Genetic reduction of BMP4 in Six1-/- mice (Six1-/-; Bmp4+/-) also restores urinary tract morphogenesis, placing Grem1 downstream of Six1 and upstream of BMP4 in this pathway.\",\n      \"method\": \"Six1 knockout mice, GREM1 protein rescue experiment, genetic epistasis (Six1-/-; Bmp4+/- double mutant), in vitro kidney rudiment culture\",\n      \"journal\": \"Developmental Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis plus protein rescue experiment, orthogonal approaches establish pathway order (Six1→Grem1→BMP4)\",\n      \"pmids\": [\"21281623\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Gremlin-1 binds various cancer cell lines independently of BMP-2, BMP-4, BMP-7, and VEGFR2. This BMP-independent binding promotes cell migration, invasion, proliferation, and EMT (decreased E-cadherin), all of which are blocked by a neutralizing anti-gremlin-1 antibody (GRE1).\",\n      \"method\": \"Cell binding assays, antibody blocking, scratch wound healing assay, invasion assay, stable gremlin-1 transfection, E-cadherin immunostaining\",\n      \"journal\": \"PLoS ONE\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — multiple functional readouts with antibody neutralization confirming specificity; BMP- and VEGFR2-independence tested directly; single lab\",\n      \"pmids\": [\"22514712\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Gremlin (VEGFR2 agonist) binds to VEGFR2 in renal proximal tubular epithelial cells and activates VEGFR2 signaling independently of its BMP antagonism. In vivo administration of recombinant gremlin to murine kidneys activates VEGFR2 signaling and triggers NF-κB-driven renal inflammation and immune cell infiltration; VEGFR2 blockade diminishes these effects.\",\n      \"method\": \"Recombinant gremlin administration in vivo and in vitro, VEGFR2 binding assay, VEGFR2 kinase inhibitor treatment, co-immunoprecipitation/binding in tubular cells, NF-κB activation by Western blot, histological analysis of inflammatory infiltrate\",\n      \"journal\": \"Journal of Pathology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct binding demonstrated, in vivo and in vitro functional validation, receptor pathway blockade confirming mechanism; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"25810250\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Gremlin 1 defines a skeletal stem cell population (osteochondroreticular, OCR) in bone marrow metaphysis that self-renews and gives rise to osteoblasts, chondrocytes, and reticular marrow stromal cells (but not adipocytes); Grem1 expression is required for bone development, bone remodeling, and fracture repair. Grem1 also identifies intestinal reticular stem cells (iRSCs) that are cells of origin for the periepithelial intestinal mesenchymal sheath.\",\n      \"method\": \"Gremlin-1-Cre fate-mapping in mice, clonal analysis, in vivo bone development and fracture repair models, flow cytometry, transplantation assays\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Cre-based in vivo fate mapping plus functional depletion and transplantation, multiple independent phenotypic readouts\",\n      \"pmids\": [\"25594183\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Gremlin 1 (along with FRZB and DKK1) inhibits hypertrophic differentiation of human articular chondrocytes, maintaining cartilage homeostasis. Supplementation of these proteins diminishes terminal hypertrophic differentiation without affecting chondrogenesis in long-bone explant cultures and in chondrogenically differentiating human MSCs.\",\n      \"method\": \"Recombinant protein supplementation in long-bone explant cultures and human MSC chondrogenic differentiation; gene expression profiling; whole-genome microarray\",\n      \"journal\": \"Arthritis and Rheumatism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — functional rescue with recombinant protein in two model systems; single lab\",\n      \"pmids\": [\"22576962\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Gremlin induces ocular hypertension in mice via Smad3-dependent signaling in the trabecular meshwork (TM): intravitreal Ad5.Gremlin elevates IOP and upregulates fibronectin and collagen-1 expression in TM of Smad3 wild-type but not Smad3 HET or KO mice. Gremlin and TGFβ2 reciprocally increase each other's expression in the TM.\",\n      \"method\": \"Intravitreal adenoviral injection in wild-type vs. Smad3 knockout mice, IOP measurement, Western blot, immunofluorescence, qPCR\",\n      \"journal\": \"Investigative Ophthalmology & Visual Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis (Smad3 KO) combined with in vivo gain-of-function, multiple readouts; single lab\",\n      \"pmids\": [\"26284554\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Gremlin 1 is a key pro-fibrogenic factor in chronic pancreatitis: TGF-β induces Grem1 expression in pancreatic stellate cells; Grem1 blocks BMP2-induced Smad1/5 phosphorylation and abolishes BMP2's suppression of TGF-β-induced collagen expression. Grem1+/- mice show ~33% reduction in pancreatic fibrosis.\",\n      \"method\": \"Mouse CP model (cerulein), Grem1+/- knockout mice, isolated pancreatic stellate cell cultures, recombinant Grem1 protein treatment, Smad1/5 phosphorylation Western blot, collagen quantification\",\n      \"journal\": \"Journal of Molecular Medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic loss-of-function in vivo plus in vitro biochemical mechanism (Smad1/5 phosphorylation), TGF-β induction of Grem1 shown; multiple orthogonal methods\",\n      \"pmids\": [\"26141517\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Crystal structure of Gremlin-1 reveals a conserved dimeric structure similar to other DAN family inhibitors. Biophysical analysis shows Gremlin-1 and BMP-2 form larger oligomeric complexes beyond 1:1 stoichiometry. Mutagenesis mapped the Gremlin-1 binding site on BMP-2, revealing a mechanism of BMP inhibition distinct from Noggin and Chordin.\",\n      \"method\": \"X-ray crystallography (crystal structure of Gremlin-1), biolayer interferometry (BLI) binding kinetics, site-directed mutagenesis of BMP-2\",\n      \"journal\": \"Biochemical Journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structure plus biophysical binding quantification plus mutagenesis; single lab but multiple rigorous orthogonal methods\",\n      \"pmids\": [\"27036124\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"GREM1 is a direct transcriptional target of CDX2 and TCF7L2 (Wnt effector): the CRC risk allele at rs16969681 lies in active chromatin with enhancer activity; CDX2 and TCF7L2 bind this region with higher affinity for the risk allele, driving stronger GREM1 expression. Higher Grem1 mRNA increases intestinal tumor burden in ApcMin mice.\",\n      \"method\": \"Chromatin accessibility/enhancer reporter assay, allele-specific CDX2/TCF7L2 binding assay, CDX2 overexpression-driven GREM1 re-expression, ApcMin mouse model with Grem1 dosage manipulation\",\n      \"journal\": \"Cell Reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (chromatin assay, TF binding, in vivo mouse model); single lab\",\n      \"pmids\": [\"25131200\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Gremlin activates the Notch signaling pathway in kidney tubular cells: recombinant gremlin upregulates Jagged-1, induces nuclear translocation of active Notch-1 (N1ICD), and upregulates Notch effectors hes-1 and hey-1 in vitro and in vivo. This Notch activation is linked to NF-κB-mediated renal inflammation.\",\n      \"method\": \"In vitro tubular cell culture, in vivo murine renal gremlin injection, γ-secretase inhibitor (DAPT) Notch blockade, Western blot for N1ICD, gene expression analysis\",\n      \"journal\": \"Clinical Science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — both in vitro and in vivo evidence for pathway activation, pathway inhibitor confirms mechanism; single lab\",\n      \"pmids\": [\"29720422\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"SLIT2 and Gremlin interact directly: the SLIT2-Gremlin interaction inhibits both SLIT2-ROBO2 signaling in neurons and Gremlin antagonism of BMP activity in myoblasts and fibroblasts. BMP2 down-regulates SLIT2 expression through canonical BMP/SMAD4 signaling; Gremlin treatment, BMP receptor inhibition, or SMAD4 knockdown rescues SLIT2 repression—revealing negative cross-talk between the SLIT2 and BMP-Gremlin pathways.\",\n      \"method\": \"Direct binding assays, SLIT2-ROBO2 signaling assay in neurons, BMP activity assay in myoblasts/fibroblasts, SLIT2 promoter activity assay, SMAD4 knockdown, BMP receptor inhibition\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — direct binding, functional epistasis in multiple cell types, promoter assay, and genetic knockdown; multiple orthogonal methods in single study\",\n      \"pmids\": [\"29317497\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Cancer-associated fibroblast (CAF)-derived Grem1 abrogates BMP/SMAD signaling in breast cancer cells, promoting mesenchymal phenotype, stemness, and invasion. TGF-β secreted by breast cancer cells stimulates GREM1 expression in CAFs. Grem1 also promotes fibrogenic activation of CAFs and breast cancer cell intravasation and extravasation in zebrafish xenograft models.\",\n      \"method\": \"In situ hybridization, recombinant protein treatment, SMAD signaling assay, functional cell-based assays (stemness, invasion), collagen contraction assay, zebrafish xenograft co-injection model\",\n      \"journal\": \"Breast Cancer Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — multiple functional assays plus in vivo zebrafish model; single lab\",\n      \"pmids\": [\"31533776\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"GREM1 promotes breast cancer cell metastasis by activating STAT3, which drives MMP13 transcription. GREM1 knockdown reduces tumor growth and lung metastasis in an orthotopic mouse model.\",\n      \"method\": \"GREM1 knockdown/overexpression, orthotopic mouse model, STAT3 activation assay, MMP13 expression analysis, migration/invasion assays\",\n      \"journal\": \"International Journal of Molecular Sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — in vitro pathway activation combined with in vivo model; single lab\",\n      \"pmids\": [\"33287358\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Gremlin-1 activates VEGFR2-Akt-mTORC2 signaling in retinal pigment epithelial (RPE) cells to promote cell proliferation, migration, and VEGF production; VEGFR2 inhibition or knockdown, and mTORC2 component knockdown (Rictor, Sin1), abolished these effects.\",\n      \"method\": \"Pharmacological inhibition (SU5416), shRNA knockdown of VEGFR2/mTORC2 components, Western blot for p-Akt/mTORC2, proliferation/migration assays, VEGF ELISA\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — multiple pathway inhibitors and knockdowns confirm VEGFR2-Akt-mTORC2 axis; single lab\",\n      \"pmids\": [\"27894090\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"GREM1 in rheumatoid arthritis fibroblast-like synoviocytes (RA-FLS) promotes cell proliferation, survival, migration, and invasion via αvβ3 integrin signaling: GREM1 siRNA reduces pErk1/2, pAkt, and Bcl2 while increasing Bax expression; these effects are completely blocked by anti-αvβ3 integrin neutralizing antibodies.\",\n      \"method\": \"siRNA knockdown, recombinant GREM1 treatment, αvβ3 integrin neutralizing antibody, Western blot for signaling proteins, cell proliferation/migration/invasion assays\",\n      \"journal\": \"Journal of Rheumatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — integrin neutralization identifies receptor mediating BMP-independent signaling; multiple functional and biochemical readouts; single lab\",\n      \"pmids\": [\"26834210\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"GREM1 activates Akt/STAT3 signaling to increase glycolysis in breast cancer cells by upregulating hexokinase-2 (HK2) expression; this operates via a ROS-Akt-STAT3 axis and increases glucose uptake and lactate production.\",\n      \"method\": \"GREM1 overexpression, glucose uptake/lactate production assays, Western blot for STAT3/Akt/HK2, ROS measurement, signaling inhibitors\",\n      \"journal\": \"Biochemical and Biophysical Research Communications\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — functional assays with signaling Western blots; single lab, single study, no orthogonal validation of the specific ROS-Akt-STAT3-HK2 chain\",\n      \"pmids\": [\"33097188\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Stromal Grem1 upregulation from topographically distinct fibroblast populations is required for adaptive BMP pathway attenuation during intestinal regeneration after ulceration; this Grem1-mediated BMP antagonism is obligatory but functionally submaximal for regenerative stem cell reprogramming. Mechanistically, BMP pathway activation (via Bmp4) abrogates regenerative stem cell dedifferentiation despite convergent YAP/TAZ effects on cell fate.\",\n      \"method\": \"Novel mouse model (autocrine Bmp4 ligand), spatial BMP signaling mapping (mouse and human), Grem1 deletion transgenic mice, Bmp4 or Grem1 epithelial overexpression, intestinal regeneration assays\",\n      \"journal\": \"Gastroenterology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple transgenic models, spatial mapping in human and mouse tissue, functional epithelial overexpression and genetic deletion; independent replication in human tissue\",\n      \"pmids\": [\"33819486\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Grem1+ fibroblastic reticular cells (FRCs) localize at T-B cell junctions in secondary lymphoid organs and are required for homeostatic maintenance of resident conventional dendritic cells (cDCs): Grem1+ FRC depletion causes preferential loss, decreased homeostatic proliferation and survival of cDCs, and compromised T cell immunity.\",\n      \"method\": \"scRNA-seq (human and mouse lymph nodes), Grem1-CreERT2 knock-in mice for genetic depletion, multi-omics characterization, flow cytometry, functional T cell immunity assays\",\n      \"journal\": \"Nature Immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic Cre-based depletion with multiple orthogonal functional readouts; human and mouse scRNA-seq validation; independent transcriptomic and cellular phenotypic methods\",\n      \"pmids\": [\"33903764\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Grem1 inhibits the expression of EMT transcription factors Snai1 (Snail) and Snai2 (Slug) in epithelial PDAC cells, maintaining epithelial identity by suppressing BMP activity. Grem1 inactivation in established PDAC causes direct conversion of epithelial to mesenchymal cells; conversely, Grem1 overexpression causes epithelialization of mesenchymal PDAC cells. This paracrine mechanism (Grem1 expressed in mesenchymal cells, acting on epithelial cells) is required to maintain cellular heterogeneity in pancreatic cancer.\",\n      \"method\": \"Conditional Grem1 knockout in established PDAC mouse tumors, Grem1 overexpression in mesenchymal PDAC cells, time-course cell fate analysis, Snai1/Snai2 expression analysis, human PDAC validation\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — bidirectional genetic manipulation (KO and OE) in established tumors with rapid phenotypic readout, molecular mechanism identified (Snail/Slug suppression), human validation\",\n      \"pmids\": [\"35768509\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Grem1 accelerates nucleus pulposus cell apoptosis in intervertebral disc degeneration by inhibiting TGF-β-mediated Smad2/3 phosphorylation: Grem1 siRNA reduces apoptosis in TNF-α-induced degenerative NP cells and inhibits IVDD progression in vivo.\",\n      \"method\": \"siRNA knockdown, flow cytometry for apoptosis, Western blot for p-Smad2/3, immunofluorescence, in vivo IVDD rat model with local siRNA injection\",\n      \"journal\": \"Experimental & Molecular Medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — in vitro and in vivo genetic knockdown with defined pathway readout (Smad2/3 phosphorylation); single lab\",\n      \"pmids\": [\"35440754\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Grem1 depletion in adult mice causes fatal enteropathy (failure of epithelial cell replication and maturation, villous atrophy) and bone marrow failure with haematopoietic insufficiency, demonstrating an essential homeostatic role for Grem1 in maintaining intestinal epithelial renewal and haematopoiesis.\",\n      \"method\": \"Inducible Grem1 conditional knockout (ROSA26CreER-Grem1flx/flx) in adult mice, tamoxifen induction, histopathology, assessment of epithelial proliferation and bone marrow cellularity\",\n      \"journal\": \"Journal of Pathology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — inducible genetic deletion in adult animals with severe, reproducible phenotypic readouts; defined time course\",\n      \"pmids\": [\"32297672\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"GREM1 and ISLR are CAF-specific genes that antagonistically regulate stromal BMP signaling in colorectal cancer: GREM1 inhibits BMP signaling while ISLR promotes it. They mark distinct fibroblast subpopulations differentially regulated by TGF-β and FOXL1. GREM1-neutralizing antibody or fibroblast Islr overexpression reduces CRC tumoroid growth and promotes Lgr5+ stem cell differentiation. AAV8-mediated Islr delivery to hepatocytes increased BMP signaling and improved survival in a mouse liver metastasis model.\",\n      \"method\": \"Human CRC RNA analysis, in situ hybridization, CRC tumoroid assays with GREM1-neutralizing antibody, fibroblast Islr overexpression, AAV8 gene delivery in mouse hepatic metastasis model, BMP signaling assays\",\n      \"journal\": \"Gastroenterology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — neutralizing antibody, genetic overexpression, and AAV gene delivery in vivo; multiple orthogonal functional assays with pathway-level readout\",\n      \"pmids\": [\"33197448\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Gremlin-1 induces endothelial-to-mesenchymal transition (EndMT) in pulmonary artery endothelial cells (PAECs) via phospho-Smad2/3-dependent signaling; BMP-7 reverses Gremlin-1-induced EndMT by inducing phospho-Smad1/5/8 and suppressing phospho-Smad2/3.\",\n      \"method\": \"Recombinant gremlin-1 treatment, BMP-7 treatment, immunofluorescence for EndMT markers (α-SMA, VWF), Western blot for Smad phosphorylation, migration and tube formation assays\",\n      \"journal\": \"Experimental Cell Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — direct mechanistic dissection of Smad2/3 vs. Smad1/5/8 pathway balance with multiple functional readouts; single lab\",\n      \"pmids\": [\"32145252\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"In NAFLD/NASH, Gremlin 1 (expressed highly in visceral fat) is pro-senescent and antagonistic to BMP4. BMP4 is anti-senescent, anti-steatotic, anti-inflammatory and anti-fibrotic in liver cell spheroids. Both senescence and anti-senescence factors target the YAP/TAZ pathway in this context.\",\n      \"method\": \"Human liver biopsies (n=58), liver cell spheroids (stellate and hepatocyte cells), recombinant BMP4 and Gremlin 1 treatment, senescence markers, YAP/TAZ pathway assays, machine learning analysis\",\n      \"journal\": \"Nature Metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — functional spheroid experiments with direct protein treatment; pathway (YAP/TAZ) implicated; single lab\",\n      \"pmids\": [\"35995996\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Aberrant epithelial GREM1 expression (caused by the HMPS duplication) disrupts homeostatic intestinal BMP morphogen gradients, alters cell fate along the vertical epithelial axis, and promotes persistence/reacquisition of stem cell properties in Lgr5-negative progenitor cells that have exited the stem cell niche, enabling ectopic crypt formation and cancer initiation from non-stem cells.\",\n      \"method\": \"HMPS patient tissue analysis, mouse model of GREM1 epithelial overexpression, BMP gradient mapping, Lgr5 lineage tracing, histology, somatic mutation analysis\",\n      \"journal\": \"Nature Medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — human tissue combined with mouse disease model, mechanistic BMP gradient disruption demonstrated, cell-fate consequence quantified\",\n      \"pmids\": [\"25419707\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Grem1 marks a bipotent chondrogenic/osteogenic progenitor cell population within the articular surface; these progenitors are depleted by injury-induced OA and aging, and their genetic ablation causes OA in mice. Foxo1 is required for Grem1-lineage cell survival (Foxo1 ablation in Grem1-lineage cells causes OA). FGFR3 pathway activation by FGF18 drives Grem1-lineage chondrocyte progenitor proliferation, increases cartilage thickness, and reduces OA.\",\n      \"method\": \"Grem1-Cre lineage tracing, genetic cell ablation in mice, Foxo1 conditional knockout in Grem1-lineage cells, FGF18 administration, transcriptomic analysis, OA scoring\",\n      \"journal\": \"Nature Communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple genetic models (ablation, conditional KO, fate-mapping), FGF18 therapeutic intervention, multiple orthogonal functional readouts\",\n      \"pmids\": [\"37907525\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GREM1 (Gremlin-1) is a secreted, dimeric cysteine-knot glycoprotein that primarily acts as an extracellular antagonist of BMP2, BMP4, and BMP7 by forming stoichiometrically complex oligomers with BMP dimers, thereby preventing BMP receptor activation; it also signals independently of BMPs by binding VEGFR2 to drive angiogenesis, NF-κB-mediated inflammation, and endothelial/epithelial-mesenchymal transitions, and by engaging αvβ3 integrin to promote cell survival and migration; in development, GREM1 acts downstream of Six1 and is regulated by BMP/Shh cross-talk to maintain the ZPA-AER feedback loop required for limb patterning; in adult tissues it maintains intestinal epithelial homeostasis (by attenuating the BMP differentiation gradient near the crypt stem cell niche), marks skeletal and articular chondrocyte stem cell populations, and is induced by TGF-β to drive fibrosis in kidney, pancreas, and lung by blocking protective BMP signaling.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"GREM1 (Gremlin-1) is a secreted, dimeric cysteine-knot glycoprotein of the DAN family that functions principally as an extracellular antagonist of BMP2, BMP4, and BMP7, controlling BMP-dependent cell fate decisions across development, tissue homeostasis, and disease [#0, #16]. It is synthesized as both glycosylated and non-glycosylated phosphorylated forms that localize to the ER/Golgi and the external cell surface, where both cell-associated and secreted protein bind BMP-4 and block its signaling [#1]. Structural and biophysical analysis shows GREM1 forms larger-than-1:1 oligomeric complexes with BMP-2 through a binding interface mapped on the ligand, defining a mode of inhibition distinct from Noggin and Chordin [#16]. In limb development GREM1 is the principal BMP antagonist sustaining the Shh(ZPA)-Fgf(AER) feedback loop, with its own expression tuned by BMP dose and spatially restricted by Shh [#2, #6]; in kidney morphogenesis it acts downstream of Six1 and upstream of BMP4 to permit ureteric bud branching [#9]. In adult tissues GREM1 maintains homeostasis by attenuating BMP signaling near stem/progenitor niches: it marks and is required by skeletal osteochondroreticular stem cells, intestinal reticular stem cells, and articular cartilage progenitors, and its loss causes fatal enteropathy and bone marrow failure [#12, #29, #34]. Aberrant or stromally derived GREM1 disrupts the intestinal BMP gradient to reprogram non-stem progenitors and drive tumorigenesis, with expression driven by CDX2/TCF7L2 enhancer binding and by TGF-\\u03b2 in cancer-associated fibroblasts [#33, #17, #20, #30]. Beyond BMP antagonism, GREM1 signals independently of BMPs: it binds VEGFR2 to activate Akt/mTORC2 and NF-\\u03baB-driven inflammation and angiogenesis [#5, #11, #22], engages \\u03b1v\\u03b23 integrin to promote survival and migration [#23], and modulates Smad2/3 (TGF-\\u03b2) and Notch signaling to drive epithelial- and endothelial-to-mesenchymal transitions and fibrosis in kidney, pancreas, lung, and eye [#8, #15, #18, #31, #14]. GREM1 also binds SLIT1/SLIT2 in a glycosylation-dependent manner, mediating reciprocal negative cross-talk between the SLIT-ROBO and BMP-Gremlin pathways and inhibiting monocyte chemotaxis [#4, #19].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Established GREM1's foundational identity as a DAN-family BMP antagonist whose neutralization of BMP signaling controls limb outgrowth, apoptosis, and chondrogenesis, answering what this secreted protein does at the tissue level.\",\n      \"evidence\": \"Recombinant protein administration and in situ hybridization in chick limb bud\",\n      \"pmids\": [\"10556075\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve molecular stoichiometry of BMP binding\", \"Mammalian genetic requirement not yet shown\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Defined GREM1 as a secreted, glycosylated, phosphorylated glycoprotein present both at the cell surface and in the secretory pathway, with both forms competent to bind and block BMP-4, clarifying its biosynthesis and where it acts.\",\n      \"evidence\": \"Metabolic labeling, confocal immunofluorescence, 125I-BMP-4 binding and reporter assays\",\n      \"pmids\": [\"10722723\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional role of phosphorylation unresolved\", \"Structural basis of BMP binding not addressed\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Demonstrated by mouse loss-of-function that GREM1 is genetically required to sustain the ZPA-AER feedback loop for limb patterning, moving from gain-of-function to in vivo necessity.\",\n      \"evidence\": \"Mouse knockout, skeletal phenotyping, allelic complementation with limb deformity mutation\",\n      \"pmids\": [\"12808456\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Upstream regulation of Grem1 expression not defined here\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Resolved the regulatory logic of Grem1 in the limb, showing BMP dose tunes its expression and Shh restricts its domain to terminate the signaling loop.\",\n      \"evidence\": \"Bead implantation, Shh-deficient mutants, cyclopamine blockade, limb mesenchyme culture\",\n      \"pmids\": [\"16989805\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transcriptional mediators not identified\", \"Generalizability to other tissues untested\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Revealed a BMP-independent proangiogenic function, the first evidence that GREM1 signals through receptors other than BMP ligands.\",\n      \"evidence\": \"Protein purification by endothelial sprouting, migration/invasion assays, CAM neovascularization, tyrosine phosphorylation\",\n      \"pmids\": [\"17077323\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endothelial receptor identity not yet defined\", \"Intracellular signaling cascade only partly mapped\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Identified SLIT1/SLIT2 as glycosylation-dependent GREM1/DAN binding partners and linked GREM1 to inhibition of monocyte chemotaxis, broadening its interactome beyond BMPs.\",\n      \"evidence\": \"Co-immunoprecipitation/pulldown, monocyte chemotaxis and competitive binding assays\",\n      \"pmids\": [\"15528323\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Receptor mediating chemotaxis inhibition unknown\", \"Single lab, in vitro binding\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Provided early evidence that GREM1 overexpression can suppress tumorigenesis and induce p21 via a p53/MAPK-independent route, an effect later reframed against its pro-tumor stromal roles.\",\n      \"evidence\": \"Inducible/constitutive overexpression in tumor cell lines, Western blot, tumorigenicity assays\",\n      \"pmids\": [\"12135612\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of p21 transcriptional induction undefined\", \"Apparent contradiction with later pro-tumor findings unresolved\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Connected GREM1's BMP antagonism to disease, showing allelic depletion preserves renal pSmad1/5/8 and attenuates diabetic kidney injury, establishing GREM1 as a pathological BMP antagonist in fibrosis.\",\n      \"evidence\": \"Grem1+/- mice in streptozotocin diabetes, pSmad and fibrosis-marker readouts\",\n      \"pmids\": [\"19401426\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cell-type source of pathogenic Grem1 not pinpointed\", \"Upstream induction signal unaddressed here\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Placed GREM1 in a defined developmental hierarchy (Six1\\u2192Grem1\\u2192BMP4) required for ureteric bud branching, generalizing its BMP-antagonist role to kidney morphogenesis.\",\n      \"evidence\": \"Six1 knockout mice, GREM1 protein rescue, Six1/Bmp4 double-mutant epistasis, kidney rudiment culture\",\n      \"pmids\": [\"21281623\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transcriptional link Six1\\u2192Grem1 not shown\", \"Restricted to renal development\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Showed GREM1 binds cancer cells and drives migration, invasion, and EMT independently of BMP2/4/7 and VEGFR2, reinforcing a BMP-independent pro-tumor signaling arm.\",\n      \"evidence\": \"Cell binding, neutralizing antibody blocking, wound-healing/invasion assays, E-cadherin staining\",\n      \"pmids\": [\"22514712\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Receptor mediating this binding not identified\", \"Single lab in vitro\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Identified VEGFR2 as a direct GREM1 receptor driving NF-\\u03baB-mediated renal inflammation independently of BMP antagonism, giving the proangiogenic/inflammatory arm a defined receptor.\",\n      \"evidence\": \"Recombinant gremlin in vivo/in vitro, VEGFR2 binding and kinase inhibition, NF-\\u03baB and histology\",\n      \"pmids\": [\"25810250\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry of GREM1-VEGFR2 interaction undefined\", \"Relationship to BMP-binding interface unmapped\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Demonstrated that aberrant epithelial GREM1 disrupts the intestinal BMP gradient to confer stem-like properties on Lgr5-negative progenitors, defining a mechanism for GREM1-driven cancer initiation.\",\n      \"evidence\": \"HMPS patient tissue, mouse epithelial overexpression, BMP gradient mapping, Lgr5 lineage tracing\",\n      \"pmids\": [\"25419707\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Quantitative BMP threshold for reprogramming not defined\", \"Niche position dependence partly unresolved\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Established GREM1 as a marker and functional requirement of skeletal/intestinal reticular stem cell populations, linking its niche-level BMP attenuation to multilineage stem cell maintenance.\",\n      \"evidence\": \"Grem1-Cre fate-mapping, clonal/transplantation assays, bone development and fracture-repair models\",\n      \"pmids\": [\"25594183\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Grem1 protein vs. Grem1+ cell is required separable only partly\", \"Molecular niche signals upstream unclear\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Provided the structural and biophysical basis of inhibition, showing GREM1 is a DAN-family dimer forming higher-order oligomers with BMP-2 by a mechanism distinct from Noggin/Chordin.\",\n      \"evidence\": \"X-ray crystallography, biolayer interferometry, BMP-2 mutagenesis\",\n      \"pmids\": [\"27036124\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure of the GREM1-BMP complex not solved\", \"Structural basis of BMP-independent receptor binding unknown\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Extended BMP-independent signaling by showing GREM1 activates Notch (Jagged-1, N1ICD, hes-1/hey-1) linked to NF-\\u03baB renal inflammation, broadening the downstream effector repertoire.\",\n      \"evidence\": \"Tubular cell culture and in vivo gremlin injection, \\u03b3-secretase (DAPT) blockade, Western blot\",\n      \"pmids\": [\"29720422\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct receptor coupling GREM1 to Notch not defined\", \"Single lab\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Defined direct SLIT2-GREM1 binding as a node of negative cross-talk between SLIT-ROBO and BMP-Gremlin pathways, with BMP/SMAD4 repressing SLIT2.\",\n      \"evidence\": \"Direct binding, SLIT2-ROBO2 neuron assay, BMP assays in myoblasts/fibroblasts, promoter and SMAD4 knockdown\",\n      \"pmids\": [\"29317497\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological context of this cross-talk in vivo unclear\", \"Stoichiometry of SLIT2-GREM1 complex unmapped\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Identified \\u03b1v\\u03b23 integrin as the receptor mediating GREM1-driven survival, proliferation, and invasion in synoviocytes via Erk/Akt/Bcl2, assigning a receptor to the integrin-engaging arm.\",\n      \"evidence\": \"siRNA, recombinant GREM1, \\u03b1v\\u03b23 neutralizing antibody, signaling Western blots and functional assays\",\n      \"pmids\": [\"26834210\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab, RA-FLS context\", \"Direct GREM1-integrin binding not structurally defined\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Showed GREM1 activates VEGFR2-Akt-mTORC2 in RPE cells to drive proliferation, migration, and VEGF production, refining the receptor-coupled signaling mechanism.\",\n      \"evidence\": \"SU5416, VEGFR2/Rictor/Sin1 knockdowns, p-Akt/mTORC2 Western blots, functional assays\",\n      \"pmids\": [\"27894090\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Cross-talk with BMP arm not assessed\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Demonstrated that inducible Grem1 deletion in adult mice causes fatal enteropathy and bone marrow failure, proving an essential homeostatic requirement in epithelial renewal and hematopoiesis.\",\n      \"evidence\": \"Inducible conditional Grem1 knockout, histopathology, proliferation and marrow cellularity\",\n      \"pmids\": [\"32297672\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether phenotype is fully BMP-dependent not dissected\", \"Cellular source driving lethality not isolated\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Showed stromal Grem1-mediated BMP attenuation is obligatory but submaximal for regenerative stem-cell reprogramming after intestinal injury, refining its role in tissue regeneration.\",\n      \"evidence\": \"Transgenic autocrine Bmp4 and Grem1 deletion/overexpression mice, spatial BMP mapping in human and mouse\",\n      \"pmids\": [\"33819486\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Quantitative interplay with YAP/TAZ not fully resolved\", \"Fibroblast subpopulation specificity partly open\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identified Grem1+ fibroblastic reticular cells as niche cells required for dendritic cell homeostasis and T-cell immunity, extending GREM1+ stromal niche function to immunity.\",\n      \"evidence\": \"Human/mouse scRNA-seq, Grem1-CreERT2 depletion, flow cytometry, T-cell immunity assays\",\n      \"pmids\": [\"33903764\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Grem1 protein itself is the mediator vs. cell identity not separated\", \"Receptor on cDCs undefined\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Established a TGF-\\u03b2\\u2192CAF-Grem1\\u2192BMP/SMAD axis driving breast cancer stemness, EMT, and dissemination, integrating stromal regulation with tumor cell phenotype.\",\n      \"evidence\": \"In situ hybridization, recombinant protein, SMAD assays, functional assays, zebrafish xenograft\",\n      \"pmids\": [\"31533776\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Direct receptor on tumor cells not defined here\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Linked GREM1 to metastatic signaling through STAT3-driven MMP13 transcription, adding a downstream transcriptional effector for its pro-metastatic activity.\",\n      \"evidence\": \"Knockdown/overexpression, orthotopic mouse model, STAT3 and MMP13 readouts\",\n      \"pmids\": [\"33287358\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Receptor upstream of STAT3 not identified\", \"Single lab\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Showed GREM1 is a direct transcriptional target of CDX2 and the Wnt effector TCF7L2 at a CRC risk allele, mechanistically connecting genetic risk to elevated GREM1 and tumor burden.\",\n      \"evidence\": \"Enhancer reporter, allele-specific CDX2/TCF7L2 binding, CDX2 overexpression, ApcMin dosage model\",\n      \"pmids\": [\"25131200\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Tissue-specificity of enhancer activity in vivo only partly resolved\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Demonstrated bidirectionally (KO and OE in established PDAC) that paracrine Grem1 suppresses Snail/Slug to maintain epithelial identity and tumor cell heterogeneity, a striking cell-fate stabilizing role.\",\n      \"evidence\": \"Conditional Grem1 KO and OE in mouse PDAC, time-course fate analysis, human validation\",\n      \"pmids\": [\"35768509\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Receptor mediating epithelial response not defined\", \"Whether purely BMP-mediated not fully isolated\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Defined GREM1/ISLR as antagonistic CAF-derived regulators of stromal BMP signaling in CRC, with GREM1 neutralization or ISLR delivery suppressing tumor growth and promoting stem-cell differentiation.\",\n      \"evidence\": \"Human CRC RNA, in situ hybridization, tumoroid + neutralizing antibody, Islr overexpression, AAV8 in vivo\",\n      \"pmids\": [\"33197448\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of FOXL1/TGF-\\u03b2 control of subpopulations partly open\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Showed GREM1 marks bipotent articular cartilage progenitors whose depletion causes OA, with Foxo1 required for their survival and FGF18/FGFR3 promoting their expansion, defining a regenerative target in joint disease.\",\n      \"evidence\": \"Grem1-Cre lineage tracing, genetic ablation, Foxo1 conditional KO, FGF18 administration, transcriptomics\",\n      \"pmids\": [\"37907525\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Grem1 protein vs. Grem1+ cell drives chondroprotection not separated\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Implicated GREM1 across fibrotic and degenerative diseases through differential Smad balance, antagonizing protective BMP and modulating TGF-\\u03b2/Smad2/3 in lung EndMT, disc apoptosis, ocular hypertension, and NASH senescence.\",\n      \"evidence\": \"Recombinant protein and knockdown studies, Smad phosphorylation, Smad3-KO epistasis, spheroid and in vivo models\",\n      \"pmids\": [\"32145252\", \"35440754\", \"26284554\", \"35995996\", \"26141517\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Receptor specificity for TGF-\\u03b2/Smad2/3 effects not defined\", \"Cross-tissue generalizability uncertain\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How GREM1's BMP-antagonist surface relates structurally to its BMP-independent receptor engagements (VEGFR2, \\u03b1v\\u03b23 integrin, SLIT2) and how a single secreted factor selects among these outputs in a given tissue remains unresolved.\",\n      \"evidence\": \"No structural model of GREM1 bound to VEGFR2 or integrin is available in the corpus\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structure of GREM1 with any non-BMP receptor\", \"Determinants of context-dependent BMP-dependent vs. -independent signaling unknown\", \"Reconciliation of tumor-suppressive vs. pro-tumor activities incomplete\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 1, 16, 15, 8]},\n      {\"term_id\": \"GO:0140313\", \"supporting_discovery_ids\": [0, 16]},\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [11, 22]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [0, 1, 5]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [1]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [1]},\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [1]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 11, 16, 18, 23]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [2, 6, 9, 12, 34]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [8, 15, 33, 27, 30]},\n      {\"term_id\": \"R-HSA-1474244\", \"supporting_discovery_ids\": [14, 8]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"BMP2\", \"BMP4\", \"BMP7\", \"VEGFR2\", \"ITGAV\", \"ITGB3\", \"SLIT2\", \"SLIT1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}